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Introduction 
INTRODUCTION 
The gastrointestinal tract is home to 10 times more bacteria than cells in the 
entire human body. It is the site of sophisticated interactions between microbial 
pathogens,  commensals, host epithelial cells and the immune system, a kind of jungle 
of biologic interactions, evolution and natural history whose balance is crucial for 
childhood growth and development.59 
 
Diarrhoea is one of the most common causes of morbidity and mortality in 
children worldwide. Globally, there are about two billion cases of diarrhoeal disease 
every year106.Diarrhoeal disease is the second leading cause of death in children under 
five years of age  with an estimated 1.5 million child deaths every year.  It kills more 
young children than AIDS, malaria and measles combined99. 
 
Diarrhoeal disease continues to be a public health problem especially in 
developing countries  where they are estimated to be responsible for 2.5 million infant 
deaths per year with an annual mortality rate of 4.9/ per 1000 children and an 
incidence of of 3.2 episodes of diarrhoea per child-year among children under 5 years 
of age. 50n  
 
In India ,one third of total paediatric admissions in hospitals are due to 
diarrhoeal diseases and 17% of all deaths in indoor paediatric patients are diarrhoea 
related76. Diarrhoea is the cause of death in almost 23% of Indian children who die 
before the age of 5.40 
 
In developing countries , diarrhoeal disease is most commonly due to infectious 
cause.28 Although many number of viral , bacterial and parasitic causes of diarrhoea 
have been identified todate , only a few of the etiologic agents cause the vast majority 
of diarrhoeal disease in children in the developing world and include rotavirus, 
diarrhoeagenic Escherichia coli, Campylobacter jejunii, Shigella sp, nontyphoidal 
Salmonella ,Giardia lamblia, Cryptosporidium sp and Entamoeba histolytica.91 Many 
of these organisms are transmitted easily through food or water or from one person to 
another and some are devastating to individuals with compromised immune system.78 
 
Diarrhoeagenic Escherichia coli pathotypes represent a leading bacterial cause 
of paediatric diarrhoea in developing countries. The diarrhoeagenic Escherichia coli 
increasingly being reported in recent years is the Enterohaemorrhagic E.coli38 .The 
enterohaemorrhagic E.coli cause severe disease in humans such as haemolytic uremic 
syndrome by the production of shiga toxin16.  
 
Worldwide the incidence of shigellosis is highest among children 1 to 4 years 
old49. In developing countries, shigella infections most commonly caused by 
S.flexneri are mainly endemics causing approximately 10% of all diarrhoeal episodes 
among children less than 5 years of age.  It is estimated that shigella causes 164.7 
million cases of diarrhoea of which 163.2 million occur in developing countries, and 
1.1 million deaths each year worldwide mostly in developing countries6. Regarding 
parasitic causes, Entamoeba histolytica, Cryptosporidium, and Giardia are common in 
developing countries. 
Rotavirus disease is the single most important cause of severe gastroenteritis in 
children throughout the world 3,7,67. Globally about 30%–40% of hospitalizations and 
deaths due to diarrhoea among children under 5 years old, and about 5% of all child 
deaths, are attributed to rotavirus infection96,26. It occurs as a sporadic seasonal form, 
even as severe gastroenteritis of infants and younger children, mostly in the first 2–3 
years of life, with a peak at the age of 6–24 months.26 
 
  Every year, rotavirus gastroenteritis is estimated to cause approximately 
527,000(475,000-580,000) deaths globally among children <5 years old107. Of about 
500,000 annual deaths due to rotavirus worldwide, more than 1,50,000 occur in 
India103 and risk of rotavirus disease–associated death by 5 years of age is 1/250 in 
India75. 
 
 The burden of this frequent, potentially serious childhood disease in India could 
be reduced by routine rotavirus vaccination of infants because the efforts to decrease 
the number of deaths due to diarrhoea by improving water quality and sanitation, 
promoting breast-feeding, and introducing treatment programs based on oral 
rehydration therapy have decreased the mortality rate associated with infection due to 
bacterial and parasitic agents but they have been less effective in reducing rotavirus 
disease–associated morbidity and mortality102.  
 
For rota viral infections, epidemiological studies can be used to select areas for 
vaccine trials depending upon disease burden and to serve as baselines for 
identification of new strains should they emerge72.The epidemiology of rota virus in 
India remains in constant flux. So continuous monitoring of rota virus genotype 
distribution would be valuable to show up the diversity and changes in the circulating 
strains. 
 
Since optimal therapy depends on the identity of the infective agent, definitive 
microbiologic studies are essential42. The treatment of bacterial enteric infection 
depends on the infective agent. For example some organisms such as 
enterohaemorrhagic E.coli, nontyphoidal Salmonella , antimicrobial therapy is not 
required as it increase the complication. In contrast, enteric fever and shigellosis 
benefit from antimicrobial treatment.  
 
Because laboratory tests for faecal specimens are time consuming and 
expensive, their inclusion in routine patient management usually is limited in 
nonhospitalized patients to those with severe diarrhoea. Young children are at 
particular risk of severe diarrhoeal disease and can benefit from appropriate laboratory 
support19. Further, identifying the enteric pathogens that contribute significantly to the 
causes of diarrhoea in children will help to provide an accurate and region specific 
estimate of disease burden91. 
 
Hence this study was undertaken to identify the bacterial, parasitic profile and 
rota viral infections in children under 5 years of age with diarrhoea and from children 
under 5 years of age presenting to hospital for reasons other than diarrhoeal illness. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aims and Objective 
 Of The Study 
 
AIMS AND OBJECTIVES OF THE STUDY 
 
 
¾ To determine the prevalence of bacteria and parasites in stool samples 
from diarrheal cases of children under 5 years of age. 
¾ To find antibiotic susceptibility of significant bacterial isolates. 
¾ To determine the incidence of rota virus infection in children under 5 
years of age with acute diarrhoea. 
¾ To examine the age distribution of rota virus infected children. 
¾ To evaluate clinical severity of rota virus infection in children. 
¾ To evaluate the protective effect of breast feeding on rota virus 
diarrhoea. 
¾ To evaluate the distribution of different genotypes of rotaviruses 
circulating in the community.  
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Review Of Literature 
REVIEW OF LITERATURE 
The term ‘diarrhoea’ is derived from Greek and it means ‘to flow through’. It is 
defined as a condition characterized by an increase in the frequency, fluidity and 
weight of the stool, compared to the normal bowel habit of the child. Diarrhoea is 
usually a symptom of an infection in the intestinal tract, which was described by 
Hippocrates as ‘the abnormal frequency and liquidity of faecal discharge’ 2000 years 
back84. 
 
Diarrhoeal diseases are 1.one of the most common illness in infants and young 
children throughout the world. 2.one of the six leading causes of 10.6 million deaths 
that occur annually in children younger than 5 years of age 3.Account for 18% of the 
10.6 million deaths with the greatest toll being in the developing countries13.  
 
Normal defences of the bowel include 1.Gastric acid 2.Bile salts 3.Lymphoid 
tissue 4.Enterokines 5.Normal bowel flora 6.Secretory immunoglobulin A 7.Motility 
8.Hepatic deactivation of toxins.  
 
  Diarrhoea may be classified as ‘acute’ if it lasts for less than 2weeks, 
‘persistent’ if the duration of diarrhoea is 2-4 weeks and ‘chronic’ if more than 4 
weeks duration86. 
 
 
 
 
 
Acute diarrhoea may be due to following reasons35: 
1. Infectious 90 % 
2. Drug induced 
3. Ingestion of toxins 10 % 
4. Ischemia 
5. Other conditions 
 
Infectious diarrhoea may be caused by viruses, bacteria and protozoa. These 
agents of diarrhoea are acquired by ingestion of contaminated food or water and 
transmitted by faeco-oral route97. Infectious diarrhoea can be classified into 2 distinct 
clinical syndromes : inflammatory or bloody diarrhoea and noninflammatory or 
nonbloody diarrhoea22. Inflammatory diarrhoeas produce severe form of acute 
diarrhoea. In contrast, noninflammatory diarrhoeas are milder but produces severe 
fluid loss with attendant morbidity and mortality51. 
 
PATHOGENESIS43: 
Enteric pathogens adhere to mucosal cells via fimbrial or afimbrial microbial 
adhesions and induce formation of cuplike pedestals on which bacteria rest. After this 
interaction, the pathogenesis of the bacteria depends on whether the organism remains 
adherent to the cell surface and elaborates a secretory toxin, invades the mucosa or 
penetrates the mucosa. 
 
 
 
Pathogenesis : 
Characteristic noninflammatory 
[secretory,noninvasive,toxin 
producing] 
inflammatory 
[mucosal,invasive] 
penetrating 
[systemic] 
Mechanism Activation of adenyl cyclase34, 
Activation of guanylate cyclase, 
Alteration of intracellular 
calcium, 
Stimulation of enteric nervous 
system, 
Loss of brush border hydrolase 
activity, 
Unopposed crypt cell secretion20 
 
Invasion, 
Cytotoxin 
Penetrating 
Location57 Proximal small bowel Colon Distalsmallbowel
Illness Watery diarrhoea Dysentery Enteric fever 
Stool 
examination 
No faecal leucocytes 
Mild or no ↑lactoferrin 
Faecalpolymorpho 
nuclear leukocytes 
↑↑lactoferrin 
Faecal 
mononuclear 
leukocytes 
Etiological 
agents 
Vibrio cholerae, 
Escherichia coli(ETEC*) 
Clostridium Perfringens 
Bacillus cereus 
Staphlococcus aureus 
Giardia lamblia 
Rota virus 
Norwalk like viruses 
Cryptosporidium parvum 
E.coli(EPEC,EAggEC)* 
Microsporidia 
Cyclospora cayetanensis 
Shigella 
E.coli(EIEC,EHEC)*
Salmonella 
enteriditis 
Vibrio 
parahemolyticus 
Clostridium difficile 
Campylobacter 
jejuni 
Entamoeba 
histolytica 
Salmonella typhi 
Yersinia 
enterocolitica 
 
 
*  ETECEnterotoxigenicE.coli, EHECEnterohaemorrhagicE.coli, 
EIEC-EnteroinvasiveE.coli, EPEC-EnteropathogenicE.col, 
EAggEC-Enteroaggregative E.coli 
 
The causes of acute diarrhoea in children are27: 
Viruses:(70%) Bacteria:(10-20%) Parasites 
 Rota viruses 
 Noroviruses(Norwalk 
like viruses) 
Enteric adeno viruses 
Calciviruses 
Astro viruses 
 
EnteropathogenicEscherichia coli 
Shigella spp 
Nontyphoid Salmonella spp 
Campylobacter jejuni 
Yersinia enterocolitica 
Shigatoxin producing E.coli 
Salmonella typhi and Salmonella 
paratyphi 
Vibrio cholerae  
Protozoa: 
Cryptosporidium 
Giardia lamblia 
Entamoeba 
histolytica 
Helminths: 
Strongyloides 
stercoralis 
 
 
VIRAL GASTRO ENTERITIS: 
 
Viral gastro enteritis is a global problem in infants and young children9. 
Viruses were long suspected to cause gastro enteritis but efforts to demonstrate 
specific agents were not successful until the 1970s when the Norwalk agent was first 
observed by electron microscopy in negatively stained stool suspensions44. 
 
Viruses are suspected when vomiting is prominent, the incubation period is 
longer than 14 hours and the entire illness is over in less than 72 hours. Viral 
pathogens are likely when there are no warning signs of bacterial infection and there 
are no epidemiologic clues from the history22. 
 
Viruses causing gastroenteritis10: 
Rota viruses                           -  genus Reoviridae 
Noro viruses and Sapo viruses  - genus Calciviridae 
Astro viruses                               - genus Astroviridae 
Enteric adeno viruses  - group F of Adenoviridae 
Incidence in Children11,73: 
Rota viruses    30-60% 
Noro viruses and Sapo viruses  8-30% 
Astro viruses    6-9% 
Enteric adeno viruses  3-6% 
 
Other viruses found in the gastro intestinal tract that are not regularly 
associatedwithdiarrhoea:Enteroviruses, Reoviruses,Toroviruses,Coronaviruses, 
Parvoviruses. Human immune deficiency virus can infect the gut directly. 
 
Viruses which infect the gut under conditions of immune suppression: Herpes 
simplex viruses, Cytomegalovirus, Picobirnavirus. 
 
 
 
 
 
 
 
 ROTA VIRUS: 
Introduction: 
Rota viruses are the single most important cause of severe diarrhoeal illness in 
infants and young children in both developing and developed countries worldwide 
accounting for 30-50% of these illnesses74.  
 
History27: 
In 1973, Ruth Bishop et al identified round viral particles termed ‘rotavirus’ by 
electron microscopy in duodenal biopsies of infants with gastroenteritis in Melbourne. 
Shortly afterward rotavirus was identified in faeces by electron microscopy by  
Flewett et al and Bishop et al . Although the human rotaviruses were discovered in 
1973, Adams and Kraft described virus like particles in intestinal tissue of mice 
infected with epizootic diarrhoea of infant mice virus in 1963. These particles were 
similar to those observed in children by Bishop et al. In 1963, Malherbe et al 
described the isolation of  simian agent 11 virus. In 1967, Malherbe et al described 
offal agent from intestinal  washings of cattle and sheep. In 1969, Mebus et al reported 
Nebraska calf diarrhoea virus in fetal bovine cell cultures. The murine, simian, offal  
agent and bovine agents were later found to exhibit characteristic rota virus 
morphology and to share a group antigen with other rota viruses.  
 
Epidemiology: 
Almost all children are infected with rotavirus in early childhood.  In 
developing countries, 65–80% of children have antibodies to rotavirus by 12 months 
and 95% have been infected by 24 months. In general, children infected with 
rotaviruses during the first 3 months of life are asymptomatic, while those infected for 
the first time after the age of 3 months are usually symptomatic. Because natural 
infection confers some immunity to disease on subsequent exposures and because this 
protection increases with each subsequent exposure, the highest rates of rotavirus 
disease occur between 3 months and 2 years of age101. In many developing countries, 
however, the highest rates of illness occur among children aged 6–11 months. The 
incidence of rotavirus diarrhoea is similar among children in developed and 
developing countries. Attempts to control infection by improving water or food are 
therefore unlikely to alter the incidence of infection12.Humans appear to be the main 
reservoir of rotavirus infections. The exact modes of transmission are unknown but 
are presumed to involve droplet or direct contact spread via the faecal-oral route. 
 
 Rotavirus disease burden104  
Rotavirus infects nearly every child by the age of 3-5 years. The median age of 
a primary rotavirus infection is younger in developing countries, ranging from 6 to 9 
months (80% occur among infants <1 year old). Developing countries often exhibit 
one or more periods of more intense rotavirus circulation against a background of 
year-round rotavirus transmission and a great diversity of rotavirus strains. Every 
year, rotavirus gastroenteritis is estimated to cause approximately 527,000 (475,000-
580,000) deaths globally among children <5 years old. Most of these deaths occur in 
developing countries and 90% of the rotavirus-associated fatalities occur in Africa and 
Asia alone. Globally, >2 million children are hospitalized each year for rotavirus 
infections. 
 Structure ,genome and gene protein assignment: 
 
The term ’rota’ (latin word ) means a ‘wheel’. It is a double stranded RNA 
virus 65-70 nm in size, resembling little wheels with short spokes radiating from a 
wide hub to an outer rim.  
 
Rota viruses have a genome of 11 segments of double stranded RNA. The 
RNA segments code for six structural proteins (VP1,VP2,VP3,VP4,VP7) and six 
nonstructural proteins(NSP1-NSP6). 
 
The structural proteins make up a triple layered particle and are located in the 
core (inner layer;VP1-3),inner shell(intermediate layer;VP6) and outer shell (outer 
layer;VP4,VP7). The wheel like appearance by electron microscopy of the triple 
layered particles is diagnostic. 
The genome is compromised within the core shell formed by VP2. The 
transcription complex consisting of VP1 and VP3 is attached at the 12 five fold 
symmetry positions on the inside of the shell. The addition of VP6 (260 trimers) 
produces double layered particles, and further addition of VP7 (780 molecules) and 
VP4 (60 dimers) leads to formation of triple layered particles which are infectious 
virions after VP4 cleavage21. 
 
The triple layered capsid is ordered  in five-, three-, and two fold symmetry 
axes and is perforated by 132 aqueous channels. The class I channels are necessary 
components to allow transcription in sub viral particles110 
 
Genes, gene protein assignments, and functions of proteins of group A rota 
virus21 
 
RNA 
segment Protein product functions 
No. Size 
(bp) 
Description location No.of 
molecules 
Per virion 
 
1. 3302 VP1 Inner core 12 RNAdependentRNA 
polymerase;binds 
ssRNA;complex with VP3 
2 2690 VP2 Core 120 Binds RNA ;required for 
replicase activity of VP1 
3 2591 VP3 Inner core 12 Guanyltransferase,Methyl 
transferase;complex with 
VP1 
4 2362 VP4 Outer 
capsid(dimer) 
120 Hemagglutinin;cell 
attachment;neutralization 
antigen;fusogenic;protease 
enhanced infectivity 
5 1611 NS53,NSP1  
(VP5) 
Nonstructural Not 
applicable 
Binds RNA;nonessential 
for replication 
6 1356 VP6 Inner 
capsid(trimer) 
780 Group and subgroup 
specific 
antigen;protection(?intrace
llular 
neutralization)required for 
transcription 
7 1059 VP9(NSP3) Nonstructural 
(dimer) 
Not 
applicable 
Binds RNA and eIF-
4G1;inhibits host cell 
translation 
8 1104 NS35,NSP2 
(VP8) 
Nonstructural 
(octamer) 
Not 
applicable 
Binds RNA; 
NTPase;helicase;involved 
in +strand RNA packaging
9 1062 VP7 Outercapsid 
(trimer) 
780 Neutralization 
antigen;binds ca  
10 751 VP12(NSP4) Nonstructural Not 
applicable 
Intracellularreceptor,viral 
enterotoxin;protection by 
specific ab 
11 667 VP11(NSP5) 
NSP6 
Nonstructural 
Nonstructural 
Not 
applicable 
Binds RNA ;protein 
kinase;interacts with 
NSP2,VP2 AND NSP6 
interacts with NSP5 
 
CLASSIFICATION110: 
1. According to serological cross reactivity of the inner capsid protein 
VP6,five groups (A-E) have been firmly established, and two more groups (F,G) are 
likely to exist. Within group A rota viruses, there are subgroups(I;II;I+II;nonI;nonII) 
according to exclusive reactivities with two VP6 specific monoclonal antibodies. 
 
2. As the two surface proteins (VP4 andVP7) carry neutralization specific 
antigens,a dual classification scheme has been established. The system differentiates 
G types(VP7 specific,G for glycoprotein) and P types(VP4 specific,P for protease 
sensitive protein). So far 14 diferent G types and more than 20 P types have been 
detected indicating extensive genomic diversity within group A rota viruses. 
The correlation of G serotypes and their genotypes is practically complete. For  
many P genotypes, no serotype has yet been established. Thus P serotype and 
genotype are designated separately but jointly, the latter in square brackets. 
 
As VP4 and VP7 are coded by different RNA segments and as rota viruses of 
the same group reassort  readily in doubly infected cells, the observed diversity due to 
combination of VP4 and VP7 is very large.   
 
REPLICATION21: 
Triple layered rota virus particles (infectious virions) attach to the surface of 
the host cell by its outer layer protein VP4 interacting with sialic acid or other 
receptors. After endocytosis,VP4 andVP7 are removed . The resulting double layered 
particles are transcriptionally active. The mRNAs are translated into proteins. Rota 
virus cores are formed consisting of VP2,VP1 and VP3 into which mRNA molecules 
are incorporated. Within  the core, ssRNA segments are replicated to form dsRNA 
genome. Rota virus cores interact with VP6 to form double layered particles(DLPs) 
which in turn aggregate to form viroplasm. DLPs bud through rough endoplasmic 
reticulum facilitated by NSP4. In the RER, DLPs acquire VP4 and VP7 to form triple 
layered particles(TLPs).The transiently developed envelope is shed before complete 
maturation. TLPs are released by cell lysis or by non classical vesicular transport.     
 
PATHOGENESIS110: 
1.  Extensive cellular necrosis of the gut epithelium leads to villous 
atrophy, loss of digestive enzymes, a reduction of absorption and 
increased osmotic pressure in the gut lumen, resulting in the onset of 
diarrhoea. 
2.  This is followed by a reactive crypt cell hyperplasia accompanied by 
increased fluid secretion. 
3. Viral factors: VP4,VP3,VP7 and NSP1,NSP2,NSP4  NSP4 as an 
enterotoxin increases intracellular calcium concentration disturbing the 
cellular homeostasis. 
 
CLINICAL FEATURES: Incubation period:1-2 days 
Sudden onset of watery diarrhoea lasting 4-7 days,vomiting and rapid 
dehydration. Rhinorrhoea, congestion of tympanic membrane and pharynx,perianal 
excoriation may be present. Depending upon the degree of dehydration, lethargy or 
even shock may be present. 
 
NATURAL PROTECTION17,79 
 
Most symptomatic rotavirus infections occur between 3 months and 2 years of 
age, with a peak incidence between 7 and 15 months. Rotavirus infections are more 
likely to be severe in children 3 to 24 months of age than in younger infants or older 
children and adults . Although children can be infected with rotavirus several times 
during their lives, initial infection after 3 months of age is most likely to cause severe 
diarrhoea and dehydration. 
 
GEOGRAPHICAL DISTRIBUTION OF ROTAVIRUS: 
 
Rotavirus infection has been reported throughout the world. Studies between 
1986 and 2006 showed that more than 51 rotavirus genotypes were found in Brazil. 
Approximately 43 of genotype was that of P[8]G1, followed by P[8]G9 and P[4]G2  . 
In Kenya, the genotype G1 was mainly observed up to the year 2002. Then G9 has 
emerged as the most predominant genotype and followed by a less frequent genotype 
G8 .Genotype P[8]G9 was mainly found throughout Latin America. In the United 
States, the G9 genotype was detected in a 1995–1996 outbreak 82. In Australia, the 
overall G9 detection rate increased up to 29 % in 200148. In Japan, G9 was mainly 
reported in 1998–1999 . In India, G9 strains were detected and were usually found in 
combination with the P[11] or P[6] genotypes at a detection rate of about 20 % .While 
genotypes G1P8, G2P4, G3P8, and G4P8 were also seen among Indian children (33 
%), strains of P6 (G1P6, G2P6, G3P6, G4P6, and G9P6), which primarily infect 
asymptomatic newborns but are rare in children with diarrhea were common in India 
(43 %) 81. The P[8]G9 was found in New Delhi in late 1998 . In Europe G1–G4 and 
G9 were the most prevalent genotypes identified: Genotype G1 was identified in 
Spain, Sweden, and the United Kingdom;G9 in Italy, France,and Belgium; and 
genotype G4 in Germany. Only the G4 and G9 genotypes70 were identified in all 
areas.  
DIAGNOSIS58 OF ROTA VIRUS: 
Rotavirus is shed in high concentration in the stool (~1011 particles/ml of 
faeces) of children with gastroenteritis. Therefore measurement of rotavirus antigen in 
the stool has been used to identify rotavirus infected patients  
 Rotavirus Detection: 
Techniques for rotavirus detection include: 
• Electron microscopy(EM) 
• Antigen detection 
1. Enzyme immunoassay (EIA) 
2.Latex agglutination and lateral flow  immunoassay (immunochromatography) 
3. Nucleic acid detection (PAGE) and 
4. Nucleic acid amplification (RT-PCR) 
 
Electron microscopy 
Electron microscopy is highly specific for detection of rotavirus and is as 
sensitive as some EIAs. However, the method is too labour intensive for routine 
detection of rotavirus in large numbers of stool specimens. In addition, EM requires 
an expensive instrument and highly trained personnel and cannot distinguish between 
rotaviruses of different groups. 
 
Antigen detection 
The most widely used methods for rotavirus diagnosis are based on detection of 
protein antigens on rotavirus particles in stool specimens. The most appropriate 
antigen detection format for large-scale surveillance studies is an EIA that uses 
rotavirus specific antibodies to capture antigen onto wells of plastic plates. The 
antigen is then detected in a colorimetric reaction using a second rotavirus-specific 
antibody coupled to a detector enzyme. The EIA format is highly sensitive and 
specific and is adaptable to large sample volumes in the 96-well plate format. The 
optical density (OD) results can be easily recorded with a standard plate reader, 
permitting analysis of results with standard computer programs. 
 
 Latex agglutination, utilizing latex particles coated with anti-rotavirus 
antibodies can be used as an alternative to EIA and rapid near patient tests using 
immunochromatographic methods are being used widely in consulting rooms. 
 
Nucleic acid detection 
Because of the large quantities of rotavirus present in stool samples from 
children with gastroenteritis, the viral nucleic acid segments can be visualized directly 
after extraction from virus particles, by electrophoresis on acrylamide gels, and 
staining with ethidium bromide or silver nitrate. After electrophoresis, human 
rotavirus Groups A, B, and C have distinct patterns of gene-segment distribution, 
designated electropherotypes. The PAGE method has sometimes been used to 
diagnose Group A rotavirus infections for surveillance studies. However, this method 
is very labour intensive and time consuming. 
 
A variety of sensitive conventional or real-time reverse-transcription 
polymerase chain reaction (RT-PCR) methods have been developed based on primers 
specific for several different rotavirus genes. These methods have been particularly 
useful in detecting rotavirus in extra-intestinal tissues, in studies of the duration of 
viral shedding in stool and the correlation between disease severity and virus load. 
RT-PCR is also useful for verifying that RNA extracts contain intact rotavirus RNA. 
However, it is relatively expensive and labour intensive and detects low copy numbers 
of rotavirus. 
Rotavirus Characterization: 
Serotyping and subgrouping with monoclonal antibodies: 
Enzyme immunoassays allow determination of rotavirus VP6 subgroup and 
VP7 serotype using serotype specific monoclonal antibodies. The five most common 
rotavirus G serotypes (G1, G2, G3, G4, G9) can be assigned a serotype directly from 
faecal material using several Enzyme Linked Immunosorbent Assay formats 
incorporating monoclonal antibodies (Mabs) that bind in a serotype-specific manner to 
the VP7 protein. Similarly, VP6 subgroupings I, II, I & II and non-I, II can be 
assigned using binding specificity of VP6 Mabs. Studies using serotyping Mabs have 
typically typed 60%-70% of strains circulating in the community. The method is rapid 
and inexpensive. 
 
VP7 serotyping:  
A disadvantage of Mab serotyping is that a substantial fraction of the 
rotaviruses in fecal specimens cannot be serotyped.  However, for some collections of 
rotavirus specimens, a large percentage of samples will need to be analyzed by RT-
PCR to determine the genotypes of the strains not typeable with Mabs. Another 
drawback of Mab serotyping is the need for continual supplies of Mabs and rotavirus 
hyperimmune antisera, both of which must be produced in animals. 
VP4 serotyping: Many cross-reactive epitopes observed between different P 
serotypes/subtypes in rotavirus field isolates precludes the use of this assay for routine 
P typing studies. 
 
VP6 subgrouping: 
 Polyclonal antibodies to the most abundant virion protein, VP6, are cross-
reactive among all human and animal rotaviruses and largely define the group 
reactivity of rotaviruses. In contrast, some Mabs to the VP6 protein react specifically 
with different rotavirus strains. 
 
Polyacrylamide gel electrophoresis (PAGE): 
Rotavirus dsRNA can be detected in clinical specimens by extraction of the 
viral RNA and analysis by electrophoresis on a polyacrylamide gel followed by silver 
staining. Rotavirus dsRNA has 11 segments. During electrophoresis through the gel, 
these negatively charged macromolecules separate according to size. The patterns of 
dsRNA can be visualized in the gel by staining with silver nitrate .The dsRNA 
extracted from Group A rotaviruses can be split into four size classes: four large 
segments, two medium-sized segments, three small segments, and the two smallest 
segments. Group A human and animal rotaviruses also display two electropherotypes: 
“long” and “short. Although this relatively time-consuming method requires a trained 
technologist, the main advantage of PAGE is the lack of ambiguity in the results. 
 
RNA extraction methods58: 
Several methods have been described for the release and/or extraction of 
rotavirus RNA from clinical specimens. The purpose of these methods is to: 
• Disrupt infected cells and microorganisms, resulting in the release of nucleic acids 
• Protect the nucleic acids from degradation 
• Remove inhibitors of amplification 
• Concentrate the target nucleic acid 
• Recover the nucleic acid in an environment suitable for its use in the PCR 
 
Method involving crude lysis of microorganisms in specimens containing a 
high concentration of the target nucleic acid might be suitable for PCR, but additional 
nucleic acid extraction procedures are typically required to remove inhibitors and 
concentrate the target nucleic acid. Crude lysis might involve physical methods, such 
as freeze-thawing or sonication, or chemical methods using detergents, enzymes, or 
chaotropic agents. Some nucleic acid extraction methods rely on the differential 
solubilities of nucleic acids and proteins in phenol and water, as in phenol-chloroform 
extraction methods, or the ability of nucleic acids to bind to silica, as in silica 
guanidinium isothiocyanate extraction methods. Concentration of extracted nucleic 
acid is accomplished by precipitation with ethanol. 
 
RT-PCR: 
Rotaviruses in clinical specimens can be detected and G and P types 
determined by extraction of the viral RNA from faecal specimens and analysis by 
semi-nested RT-PCR with primers specific for regions of the genes encoding the VP7 
(G-type) or VP4 (P-type). The objective is to obtain genotype-specific PCR products 
for analysis on an agarose gel or sequencing gel. RT-PCR of rotavirus dsRNA has 
three steps: 1) denaturation of dsRNA, 2) reverse transcription of dsRNA, and 3) 
amplification of cDNA. PCR consists of these steps: 1) heating the DNA to be 
amplified to separate the two template strands, 2) adding two primers that are 
complimentary to the region to be amplified, 3) adding a heat-stable DNA polymerase 
enzyme that catalyses the extension of the primers using the DNA strand as template, 
and 4) repeating the cycle, with the newly synthesised cDNA heat-denatured and the 
enzymes extending the primers attached to the liberated single DNA strands. 
 
RT-PCR genotyping: 
RT-PCR genotyping methods are used increasingly as a surrogate for 
serotyping. Since RT-PCR genotyping can determine both G and P types, confirm 
results, and characterize non-typeable strains with nucleotide sequencing, RT-PCR 
genotyping is the method of choice for most laboratories. 
 
Rotavirus genotyping methods are based on semi-nested RT-PCR, in which 
viral RNA extracted from fecal specimens is reverse-transcribed and amplified by 
PCR in the presence of consensus primers for the rotavirus genes specifying G (gene 
9) or P (gene 4) serotype. 
 
  The primers are selected to be homologous to strains from different serotypes, 
so that one primer pair can be used to amplify most human rotavirus strains. The 
DNAs from the first amplification cycle are used as a template in a second PCR in the 
presence of one of the original consensus primers and a mixture of genotype-specific 
primers of opposite polarity from the consensus primer, each designed to yield a 
product of different size.  
 
Issues in strain genotyping: 
1.Non typeable(NT) strains resulting from genetic variation in common strains. 
2.Non typeable strains resulting from the presence of novel strains..  
Examples include the detection of types G5, G6, G10, G12, P[11], and P[14] among 
NT strains. Although these novel strains have usually been detected at very low 
frequency, examples of high-incidence detection of such strains have also been 
reported. 
 
Other reasons for an inability to type strains: 
False-positive EIA, insufficient or degraded RNA, the presence of residual stool 
inhibitors in the RNA extract, or technical problems with the assay itself. 
 
Confirmation of results:  
Although genotyping methods have been shown to be >90% accurate, 
misidentification by RT-PCR methods does occur. Although several confirmation 
methods have been described (e.g., Southern hybridization with cDNA and 
oligonucleotide probes or serotyping methods), sequence analysis has become the 
standard for both confirmation and identification of NT strains. 
 
Other characterization methods: 
Additional characterization techniques include cultivation in cell culture to 
amplify the amount of virus present and dilute out stool inhibitors, followed by 
repetition of routine methods or sequencing. If the sequences of the VP4 and/or VP7 
genes suggest a novel serotype, it might be necessary to prepare hyperimmune sera to 
the strains and conduct cross-neutralization tests to determine if the strains are 
antigenically distinct from known rotavirus serotypes. These types of studies have 
helped demonstrate that some rare human rotaviruses arose through interspecies 
transmission of an animal rotavirus to humans. Such studies also suggest that some 
strains, both common and uncommon, probably arose through reassortment between 
human and animal rotaviruses Thus, the analysis of untypeable rotavirus strains from 
surveillance studies has been important in defining the genetic diversity and possible 
origin of many human rotaviruses. 
 
Rotavirus vaccines: 
Currently Licensed Vaccines: 
 1. Human-Bovine Rotavirus Reassortant Vaccine (RotaTeq) 
 2. Live-Attenuated Human Rotavirus Vaccine (Rotarix) 
 
Vaccine 
 Parent strain genotype Formulation Dose regimen 
RotaTeq Bovine 
rotavirus 
strain WC3, 
P7[5]G6 
5 reassortants; 4 reassortants with 
the VP7gene from G1, G2, G3, or 
G4 and 1 reassortant with the VP4 
P1A[8] gene from the human 
rotavirus parent strain with the 
remainder of the genes from the 
WC3 bovine rotavirus Parent strain
3 oral doses at 2, 4, 
and 6 months of age 
 
Rotarix Human 
rotavirus 
strain 89-12, 
P1A[8]G1 
No reassortants; RIX4414, a 
further-passaged human 
rotavirus 89-12 strain 
2 oral doses at 2 
and 4 months of age 
 
 
BACTERIAL AGENTS: 
ESCHERICHIA COLI: 
Escherichia coli was first identified by Theodor Escherich, German 
paediatrician while studying on the intestinal flora of infants. He described the 
organism in 1885 as bacterium coli commune and established its pathogenic 
properties in extra intestinal infection. 
Diarrhoeagenic E.coli is classified as65 
1. Enterotoxigenic E.coli (ETEC) 
2. Enteropathogenic E.coli (EPEC) 
3. Enterohaemorrhagic E.coli (EHEC) 
4. Enteroinvasive E.coli (EIEC) 
5. Enteroaggregative E.coli (EAEC) and 
6. Diffusely Adherent E.coli (DAEC)  
 
ETEC and EPEC are important causes of diarrhoea in infants and ETEC is a primary 
cause of traveller’s diarrhoea. Diarrhoeagenic E.coli can produce watery,cholera like 
diarrhoea (ETEC),dysentery like symptoms(EIEC),and grossly bloody 
diarrhoea(EHEC). E.coli O157:H7,one of the common EHEC serotypes was first 
described by Karmali et al in 1982. It produces shiga like toxin and is associated with 
haemolytic uraemic syndrome,especially in children77. The medium of choice for this 
organism is Sorbitol Mac conkey agar. Other tests for detection are MUG (4 methyl 
umbelliferyl beta D Glucuronide)test, latex agglutination test and PCR for detecting 
genes stx1 and stx249. 
 
SHIGELLA: 
Shigella dysenteriae ,one of the four species of Shigella ,first was isolated by 
Shiga in 1898.There are four species-S,dysenteriae,S.flexneri,S.boydii and S.sonnei. 
S.flexneri and S.dysenteriae are the predominant species in developing countries. 
Endemic Shigellosis is typically a paediatric disease with most patients below 5 years 
of age. 
SALMONELLA: 
Age specific attack rates for Salmonella infection are highest in children 
younger than 4 years of age with higher invasiveness and mortality in infants. 
Antimicrobial treatment is not indicated for patients with uncomplicated, noninvasive 
salmonella gastroenteritis because therapy may prolong the the duration of carriage. 
 
VIBRIO CHOLERAE: 
Vibrio cholerae is most dangerous vital pathogen which has morbidity and 
mortality rate higher than other organisms. 
 
PARASITIC AGENTS: 
Regarding parasitic causes, Entamoeba histolytica is common in developing 
countries. Cryptosporidium has been documented in atleast of 5% of diarrhoeal stools 
in developing countries16. Giardia has bimodal age distribution with children less than 
5 years most frequently affected. 
 
 
 
 
 
 
TREATMENT: 
The broad principles of management of acute gastroenteritis in children include 
oral rehydration therapy, enteral feeding and diet selection, Zinc supplementation and 
additional therapies such as probiotics.  
 
PREVENTION66 
Preventive strategies includes 
1. Promotion of exclusive breast feeding 
2.  Improved complimentary feeding practices like Vitamin A supplementation 
reduces childhood diarrhoea by 34%. 
3. Improved water and sanitary facilities and promotion of personal and domestic 
hygeine. 
4.  Behavioural change strategies through hand washing promotion and access to 
soap reduce the burden of diarrhoea in developing countries. 
5. Rotavirus and measles vaccinations. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials And Methods 
MATERIALS AND METHODS 
 
TYPE OF STUDY:      Cross sectional study  
PERIOD OF STUDY: Oct 2011-Nov 2012 
PLACE OF STUDY: 
 
This study was conducted at the department of Microbiology, Stanley Medical 
College, Chennai. Samples were collected from Institute of Child health, Egmore 
Chennai-3 and Institute of social paediatrics, Stanley, Chennai-1 . 
 
SELECTION OF STUDY GROUP 
 
A total of 150 children, 0-5 years of age were included in the study. The 
patients were clinically examined and selected for the study after obtaining the 
history. 
 
INCLUSION CRITERIA: 
 
Children less than 5 years of age with complaints of more than 3 episodes of 
watery stools with or without mucus and blood for a period less than 2 weeks and not 
on antibiotics or any laxatives were included in the study. 
 
EXCLUSION CRITERIA: 
Children above 5 years of age, Children with complaints of diarrhoea more 
than 2 weeks and children who acquired diarrhoeal illness after hospital admission 
were excluded from the study. 
SELECTION OF CONTROL GROUP:  
 A total of 50 children aged 5 years or below admitted to the hospital for causes 
other than diarrhoea were included as controls. 
 
ETHICAL CONSIDERATION 
Ethical and research clearance was obtained from the Ethical 
committee,Stanley Medical College. Permission to conduct the study was sought from 
the respective hospital authorities. Informed consent was obtained from parents/ 
guardians of the child before enrolment into the study. 
 
STATISTICAL ANALYSIS: 
 The matching of study and control group was analysed by students ‘t’ test for 
independent variables and the other variables were analysed by chi square test. The ‘z’ 
test of proportions between the groups was performed wherever necessary. The above 
statistical procedures were performed by the statistical package PASW(Predictive and 
Analysis Software)statistics -18 so called SPSS. The p values less than 0.05 were 
considered as significant.  
 
COLLECTION AND TRANSPORT OF STOOL SAMPLES: 
The stool samples were collected in a clean wide mouthed sterile container, 
labelled properly,   transported to the laboratory  in ice pack and processed within one 
to  two hours.  
 
 
 
MICROBIOLOGICAL ANALYSIS: 
A portion of each sample was stored in screw capped vials at -70ºc for analysis 
of rota virus.   
Macroscopic examination: 
The stool samples were examined for colour, consistency, presence of blood, 
mucus, segments of parasite or worms. 
 
Direct microscopic examination: 
Saline and Iodine wet preparations were examined for the presence of 
erythrocytes, leukocytes,trophozoites, ova and cysts of the parasites. 
 
Saline wet mount41: 
A minute portion of the faeces is diluted with  0.9% NaCl and a drop of it was 
placed on a clean glass slide. A 22×22 mm clean coverslip was carefully placed over 
the suspension avoiding air bubbles. 
 
Iodine wet mount41: 
A drop of diluted Lugol’s iodine is added to the drop of saline emulsion of 
faeces on a clean glass slide. Cover slip is put on .  Both the preparations were  
observed under low power objective and  suspicious object was examined under high 
power objective. 
 
 
 
 
 
 
 
Saline mount showing trophozoites of Giardia lamblia 
 
 
 
Iodine mount showing red blood cells and leukocytes 
             
 
Iodine mount showing red blood cells 
     
 
 
 
 
 
 
 
 
Iodine mount showing cyst of Entamoeba histolytica 
 
 
 
Iodine mount showing fertilised egg of Ascaris lumbricoides 
 
 
 
LPCB mount showing Giardia lamblia 
 
 
 
 
 
 
 
Modified Kinyouns’s Acid Fast staining method was used for detecting coccidian 
parasites in the stool specimen54. 
1. Heat fixed faecal smear was covered with a strip of a filter paper. The 
slide was flooded with Kinyoun’s carbol fuchsin and allowed to stain for 
5 min. 
2. The stain was tipped off and filter paper removed. The slide was rinsed 
briefly(3-5 sec) with 50% ethanol and then thoroughly with water. 
3. 1% sulphuric acid was used to decolorize for 2 min or until no more 
colour ran from the slide. Slide was rinsed in water and drained. 
4. Counterstaining  was done with methylene blue for 1 min. Slide was 
rinsed with water and air dried. 
5. The slide was examined under oil immersion objective.  
 
Culture:  
Samples were cultured on Mac conkey agar, Sorbitol MacConkey agar, Xylose 
lysine deoxycholate agar and Thiosulphate citrate bile salts sucrose (TCBS) agar and 
incubated at 37C overnight.  Samples were also inoculated in selenite F broth and 
alkaline peptone water, incubated for 18 and 4 h, respectively, for enrichment of 
Salmonella and Vibrio spp. and subcultured on xylose lysine deoxycholate agar and 
TCBS agar, respectively. If Vibrio cholerae was suspected, motility was observed by 
hanging drop method. From each sample the lactose positive and  lactose negative 
colonies were subjected to identification procedures. Shigella, Salmonella and Vibrio 
cholerae  isolates were serotyped by slide agglutination test using specific antisera. 
 
Modified Acid Fast stain showing Cryptosporidium parvum 
 
 
 
 
 
Modified Acid Fast stain showing pus cells 
 
 
 
 
 
 
 
Mac Conkey agar showing lactose fermenting 
colonies of Enterohaemorrhagic Escherichia coli 
 
                                  
 
 
Sorbitol Mac Conkey agar showing colonies of 
Enterohaemorrhagic Escherichia coli 
 
 
 
 
 
 
 
XLD plate showing colonies of Escherichia coli 
 
 
 
Biochemical reactions of Escherichia coli 
 
 
 
1. TSI-A/A 
2. CITRATE-NOT UTILISED 
3. INDOLE-POSITIVE 
4. GLUCOSE- FERMENTED WITH ACID AND GAS 
5. LACTOSE- FERMENTED 
6. SUCROSE-NOT FERMENTED 
7. MALTOSE-FERMENTED 
8. MANNITOL- FERMENTED 
9. XYLOSE - FERMENTED 
10. ARABINOSE- FERMENTED 
11. UREASE NEGATIVE 
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Mac Conkey agar showing non lactose 
fermenting coloniesof Shigella 
 
 
 
XLD plate showing colonies of Shigella 
 
 
 
 
 
 
 
 
 
           
 
Biochemical reactions of Shigella flexneri 
 
      
 
1. TSI-K/A 
2. CITRATE-NOT UTILISED 
3. INDOLE-NEGATIVE 
4. GLUCOSE- FERMENTED WITH ACID  
5. LACTOSE- NOT FERMENTED 
6. SUCROSE-NOT FERMENTED 
7. MALTOSE- NOT FERMENTED 
8. MANNITOL- FERMENTED 
9. UREASE NEGATIVE 
 
Slide Agglutination of Shigella flexneri 
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Biochemical reactions of Shigella dysenteriae 
 
 
 
1. TSI-K/A 
2. CITRATE-NOT UTILISED 
3. INDOLE-NEGATIVE 
4. GLUCOSE- FERMENTED WITH ACID  
5. LACTOSE- NOT FERMENTED 
6. SUCROSE-NOT FERMENTED 
7. MALTOSE- NOT FERMENTED 
8. MANNITOL- NOT FERMENTED 
9. UREASE NEGATIVE 
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Blood agar plate and TCBS plate showing colonies of  Vibrio cholerae 
 
 
Biochemical reactions of Vibrio cholerae 
     
1. TSI-A/A 
2. CITRATE- UTILISED 
3. INDOLE-POSITIVE 
4. GLUCOSE- FERMENTED WITH ACID  
5. LACTOSE- NOT FERMENTED 
6. SUCROSE- FERMENTED 
7. MALTOSE-FERMENTED 
8. MANNITOL- FERMENTED 
9. ARABINOSE- NOT FERMENTED 
10. UREASE NEGATIVE 
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Slide Agglutination of Vibrio cholera 
 
 
  
 
 
 
 
                                         String test  for Vibrio cholerae 
 
 
 
 
 
 
 
 
 Similar to study group, the stool samples from control children were also processed by 
standard microbiological procedures. 
 
The following tests were used for identification : 
Catalase, Oxidase, Indole, Triple Sugar Iron agar, Citrate, Urease,carbohydrate 
fermentation tests and motility. 
 
Antimicrobial susceptibility: 
The significant  isolates were subsequently tested for antimicrobial 
susceptibility by Kirby-Bauer disc diffusion method with antibiotics  ampicillin 10 µg 
,cefotaxime 30 µg, ciprofloxacin 5 µg,co-trimoxazole T1.25/S23.75 µg, gentamicin10 
µg,amoxy clavulanic 20/10 µg acid, tetracycline30 µg and chloramphenicol 30 µg.  
 
Mueller-Hinton agar plate was inoculated with 0.5 McFarland standard 
inoculums to obtain a lawn culture. Using sterile forceps, discs were placed over the 
agar surface, incubated at 37˚C for overnight. The results were interpreted as per 
Clinical Laboratory Standards Institute (CLSI) standards. 
 
The Escherichia coli strain ATCC 25922 was included as a quality control in all tests. 
 
 
 
 
 
Antimicrobial susceptibility of Shigella flexneri 
 
 
AMPI- AMPICILLIN, CIP- CIPROFLOXACIN, CEFO- CEFOTAXIME, 
AMX-CLAV- AMOXY CLAVULANIC ACID, GEN- GENTAMYCIN, 
COTRI- COTRIMOXAZOLE 
 
 
Antimicrobial susceptibility of Vibrio cholerae 
 
 
 
TET-TETRACYCLINE,CHLOR-CHLORAMPHENICOL,PB-POLYMYXIN, 
AMP-AMPICILLIN, COT-COTRIMOXAZOLE 
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DETECTION AND CHARACTERIZATION OF ROTA VIRUS: 
Detection of Rota virus: 
 
 Rota virus was identified from all stool samples with commercially available 
ELISA kit detecting group specific VP6 antigen for rota virus. 
1. Antigen detection: was done by Enzyme Linked Immunosorbent assay method 
(ELISA) according to manufacturer’s instruction.[ RIDASCREEN ] 
 
Test principle 
  This is a sandwich-type of  ELISA. Monoclonal antibodies against a capsid 
protein of gene 6 (VP6) of the rotaviruses are applied to the surface of the well in the 
microwell plate. This is a group-specific antigen which occurs with all rotaviruses 
which are pathogenic to humans. A suspension of the stool sample which is to be 
tested together with other monoclonal anti-rotavirus antibodies, which are conjugated 
with horseradish peroxidase, is pipetted into the well in the microwell plate for 
incubation.  
 
 
 
 
 
 
 
 
ELISA kit for rota virus antigen detection 
 
 
    
 
ELISA reader 
 
 
 
 
ELISA washer 
 
 
 
 
 In the presence of rotaviruses, a sandwich complex forms which is made up of 
the immobilised antibodies, the unattached enzyme-labelled antibodies are removed 
during a further washing phase. After adding the substrate, the attached enzyme 
changes the colour of the previously colourless solution in the wells of the microwell 
plate to blue if the test is positive. On adding the stop reagent, the colour changes from 
blue to yellow. The extinction is proportional to the concentration of rotavirus 
antigens present in the sample. 
 
Preparing the wash buffer: 
1 part wash buffer concentrate was mixed with 9 parts distilled water 
 
Preparing the samples: 
Approx. 100 µl of sample was suspended in 1 ml sample dilution buffer in a 
labelled test tube and  homogenised  by mixing in a vortex mixer. Then centrifuged  at 
5000 rpm for 5 minutes. The supernatant was used in the test. 
 
Procedure: 
All reagents were brought to room temperature. 
1. 100 µl of sample-dilution buffer (= negative control) was added to well A1 and 
B1. 
2. 100 µl of positive control was added to wells c1 and D1. 
3. 100 µl of the stool suspension added in the wells starting from E1. 
4.  Next, 2 drops (100 µl) of the enzyme-conjugated antibody [Conjugate] was 
added  and, after mixing thoroughly, incubated at room temperature (20 – 25 
°C) for 60 minutes. 
5. After incubation the wells were  washed 5 times using 300 µl wash buffer each 
time.  
6. 2 drops (100 µl) of substrate was added to each well. Then incubated the plate 
at room temperature (20 - 25 °C) for 15 minutes in the dark. 
7.  After this, 1 drop (50 µl) stop reagent was added to each well to stop the 
reaction 
8. After mixing carefully (by lightly tapping the side of the plate) absorbance was 
read at 450 nm using a reference wavelength ≥ 600 nm 
 
Test validity: 
 Negative control must be less than or equal to 0.2 
 Positive control must be more than or equal to 0.8 
 
Evaluation and interpretation: 
 Calculating the cut-off: 
  Cut-off = extinction for the negative control + 0.15 
 
Test result: 
Samples are considered positive if their extinction is more than 10 % above the 
calculated cut-off. 
Samples are considered equivocal and must be repeated if their extinction is within ± 
10 % of the cut-off. If repeating the test with a fresh stool sample again yields a value 
in the grey range, the sample must be considered negative. 
 
Samples with extinctions more than 10 % below the calculated cut-off must be 
considered negative. 
  
ELISA positive samples were subjected for characterization by RNA extraction and 
Reverse transcriptase Polymerase Chain Reaction as standardised by Invitrogen . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ELISA for rota virus antigen detection 
 
    
 
 
 
 
 
 
 
 
 
RNA EXTRACTION AND REVERSE TRANSCRIPTION: 
  RNA extraction was done  by QIAmp viral RNA  extraction method. 
 
1.  560µl of prepared Buffer AVL containing carrier RNA was pipetted into a 1.5 
ml microcentrifuge tube. 
2.  140 µl of sample was added to the Buffer AVL in the microcentrifuge tube and 
mixed by pulse vortexing for 15 s. 
3.  Incubated at room temperature for 10 min. 
4.  The tube was centrifuged briefly to remove drops from the inside of the lid. 
5.  560µl of ethanol (96-100%) was added to the sample and mixed by pulse 
vortexing for 15 s. Then  centrifuged briefly to remove drops from the inside of 
the lid. 
6. 630 µl of the solution from step 5 was applied to the QIAmp Mini column (in 2 
ml collection tube) without wetting the rim.The cap was closed and centrifuged 
at 8000 rpm for 1 min. The QIAmp mini column was placed into a clean 2 ml 
collection tube and the tube containing filtrate was discarded. 
7.  The QIAmp mini column was opened and step 6 was repeated. 
8.  The  QIAmp mini column was opened and 500µl of Buffer AW1was added. 
Then the cap was closed and centrifuged at 8000 rpm for 1 min. The QIAmp 
mini column was placed into a clean 2 ml collection tube and the tube 
containing filtrate was discarded. 
9.  The  QIAmp mini column was opened and 500µl of Buffer AW2 was added. 
Then the cap was closed and centrifuged at 14000 rpm for 3 min. The QIAmp 
mini column was placed into a clean 2 ml collection tube and the tube 
containing filtrate was discarded. Then centrifuged at full speed  for 1 min.  
10.  The QIAmp mini column was placed in a clean 1.5 ml microcentrifuge tube 
and the old collection tube with filtrate was discarded. The  QIAmp mini 
column was opened and 60µl of Buffer AVE was added for elution of RNA. 
Then the cap was closed and incubated at room temperature for 1 min and 
centrifuged at 8000 rpm for 1 min. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thermo cycler 
 
 
 
 
Agarose gel electrophoresis 
 
 
 
Gel documentation system 
 
 
 Denaturation of ds RNA: 
40 µl of extracted nucleic acid was added to 0.2 ml PCR tube and ds RNA was 
denatured at 97c for 5 min and chilling the tube on ice for 2 min. 
 
 
 
POLYMERASE CHAIN REACTION: 
G Typing PCR (VP7): 
1x mix (Full length gene , 1 st round): 
2x buffer(with dNTPs and Mgcl2)     12.5µl 
Primer VP7 F(20pmoles/ µl)     1 µl 
Primer VP7 R(20pmoles/ µl)     1 µl 
Enzyme mix (Taq polymerase and Reverse transcriptase) 0.5 µl 
RNase free  water       5 µl 
1. prepared 1st round PCR mix 
2. 25 µl of PCR mix was added to each tube. 
3. 5 µl of denatured RNA was added .  For negative control RNase free water 5 µl 
was added. 
4. The tubes were transferred to the PCR machine room. 
5. Brief spin was done in microcentrifuge 
6. The tubes were added to the thermocycler  
7. For reverse transcription ,the temperature was set to 50ºc for 30 min. 
 
 
8.For PCR, the following cycling conditions were set. 
94 ºc                                                  2 min                                            x1 
94 ºc                                           1 min 
52 ºc                                                 1 min                                            x35 
72 ºc                                           1 min 
72 ºc                                                  7 min                                             x1 
15 ºc                                            hold 
  
Genotyping: 2nd round multiplex PCR: 
For 1 x: 
2x buffer(with dNTPs and Mgcl2)     12.5µl 
Primer VP7 R(20pmoles/ µl)     1 µl 
Primer G1(20pmoles/ µl)      1 µl 
Primer G2(20pmoles/ µl)      1 µl 
Primer G3(20pmoles/ µl)      1 µl 
Primer G4(20pmoles/ µl)      1 µl 
Primer G8(20pmoles/ µl)      1 µl 
Primer G9(20pmoles/ µl)      1 µl 
Primer G10(20pmoles/ µl)      1 µl 
Enzyme mix (Taq polymerase and Reverse transcriptase) 1 µl 
RNase free  water       18.5 µl 
 
1. 2nd round PCR mix awas prepared. 
2. 40 µl of PCR mix was added to each tube. 
3. 10 µl of 1st round product was added. For negative control RNase free water 10 
µl was added 
4. The tubes were transferred to the PCR machine room. 
5. Brief spin was done in microcentrifuge 
6. The tubes were added to the thermocycler  
7.. For PCR, the following cycling conditions were set.  
 
 
 
94 ºc                                                  4 min                                            x1 
94 ºc                                            1 min 
42 ºc                                               2 min                                            x30 
72 ºc                                            1 min 
72 ºc                                            7 min                                            x1 
15 ºc                                            hold 
  
P Typing PCR (VP4): 
1x mix (Full length gene , 1 st round): 
2x buffer(with dNTPs and Mgcl2)     12.5µl 
Primer Con3 (20pmoles/ µl)     1 µl 
Primer Con2 (20pmoles/ µl)     1 µl 
Enzyme mix (Taq polymerase and Reverse transcriptase) 0.5 µl 
RNase free  water       5 µl 
 
1. prepared 1st round PCR mix 
2. 25 µl of PCR mix was added to each tube. 
3. 5 µl of denatured RNA was added. For negative control RNase free water 5 µl 
was added 
4. The tubes were transferred to the PCR machine room. 
5. Brief spin was done in microcentrifuge. 
6. The tubes were added to the thermocycler.  
7. For reverse transcription ,the temperature was set to 50ºc for 30 min. 
8. For PCR, the following cycling conditions were set. 
 
94 ºc                                               2 min                                            x1 
94 ºc                                            1 min 
50 ºc                                                  1 min                                            x35 
72 ºc                                            1 min 
72 ºc                                                  7 min                                            x1 
15 ºc                                              hold 
 
P Genotyping: 2nd round multiplex PCR: 
For 1 x: 
2x buffer(with dNTPs and Mgcl2)     12.5µl 
Primer Con3 (20pmoles/ µl)     1 µl 
Primer P4(20pmoles/ µl)      1 µl 
Primer P6(20pmoles/ µl)      1 µl 
Primer P8(20pmoles/ µl)      1 µl 
Primer P9(20pmoles/ µl)      1 µl 
Primer P10(20pmoles/ µl)      1 µl 
Primer P11(20pmoles/ µl)      1 µl 
Enzyme mix (Taq polymerase and Reverse transcriptase) 1µl 
RNase free  water       19.5 µl 
 
1. 2nd round PCR mix was prepared. 
2. 40 µl of PCR mix was added to each tube. 
3. 10 µl of 1st round product was added. For negative control RNase free water10 
µl was added 
4. The tubes were transferred to the PCR machine room. 
5. Brief spin was done in microcentrifuge 
6. The tubes were added to the thermocycler  
7.. For PCR, the following cycling conditions were set. 
 
94 ºc                                                   4 min                                            x1 
94 ºc                                             1 min 
45 ºc                                                  2 min                                            x30 
72 ºc                                             1 min 
72 ºc                                             7 min                                            x1 
4 ºc                                               hold 
 
 
 
ANALYSIS BY GEL ELECTROPHORESIS 48 
 Preparation of agarose gel89: 1.To prepare 1% agarose gel 1.5gms agarose 
powder was  mixed with 150ml of electrophoresis buffer, then heated in a microwave 
oven, mixed well until the agarose was uniformly dissolved. 2.After cooling to about 
60oC, ethidium bromide was added to the gel(final concentration 0.5 ug/ml) to 
facilitate visualization of DNA after electrophoresis. After cooling the solution, it is 
poured into a casting tray containing a sample comb and allowed to solidify at room 
temperature 3.After the gel hardens enough, the gel was mounted in  electrophoresis 
tank. 4.Electrophoresis buffer is poured into the electrophoresis tank so that the gel 
was completely immersed. 5.The comb was carefully removed.  6.Ethidium Bromide 
is mutagenic and should be handled with extreme caution. Dispose of the 
contaminated tip into a dedicated ethidium bromide waste container. 
 
Gel electrophoresis: 
1. Electrical leads were connected. As the DNA amplified by PCR was  charged 
negative, it migrates from cathode to anode. 2. 2µ l of 6 x loading buffer was added to 
each tube containing the PCR reactant and mixed. The mixture was slowly loaded into 
the slots of the submerged gel using a Micropipette.  Marker DNAs of known size was 
loaded into slots. Constant voltage of 50-150 V was applied to allow the gel run until 
the  Bromophenol Blue have migrated ¾ the length of the gel. All PCR products were 
analysed in 1% agarose gel, stained with ethidium bromide and observed under UV 
transilluminator.  
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G Genotyping: First-amplification consensus primers: 
VP7 F  5’ATG TAT GGT ATT GAA TAT ACC AC 3’ product size 881bp 
VP7R  5’ AAC TTG CCA CCA TTT TTT CC 3’  
  
Second amplification Type specific primers : 
G1 5’ CAA GTA CTC AAA TCA ATG ATG G 3’  product size 618bp 
G2  5’ CAA TGA TAT TAA CAC ATT TTC TGT G 3’ product size 521 bp 
G3  5’ACG AAC TCA ACA CGA GAG G 3’  product size 682 bp 
G4 5’ CGT TTC TGG TGA GGA GTT G 3’   product size 452 bp 
G5 5’ GTC ACA CCA TTT GTA AAT TCG 3’  product size 754 bp 
G9 5’CTA  GAT GTA ACT ACA ACT AC 3’  product size 179 bp 
G10  5’ATG TCA GAC TAC ARA TAC TGG 3’  product size 266 bp 
 
P Genotyping: 
First amplification consensus primers: 
con3  5’TGG CTT CGC CAT TTT ATA GAC A3’ product size 876 bp 
con2  5’ ATT TCG GAC CAT TTA TAA CC 3’    
 
Second amplification Type specific primers: 
P[8]  5’TCT ACT GGR TTR CAN TGC 3’   product size 345 bp 
P[4]  5’ CTA TTG TTA GAG GTT AGA GTC 3’ product size 483 bp 
P[6]   5’TGT TGA TTA GTT GGA TTC AA 3’ product size 267 bp 
P[9]   5’TGA GAC ATG CAA TTG GAC 3’  product size 391 bp 
P[10]   5’ATC ATA GTT AGT AGT CGG 3’  product size 583 bp 
P[11]  5’ GTA AAC ATC CAG AAT GTG 3’  product size 312 bp 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Observation And Results 
 
OBSERVATION AND RESULTS 
 
200 stool samples were collected from children less than 5 years of age which 
include study group of 150 children with diarrhoea and 50 controls without diarrhoea. 
 
Bacterial culture was done for the  samples and identified by standard 
microbiological procedures such as colony morphology and relevant bio-chemical 
reactions . 
 
 Saline wet mount , iodine wet mount and modified acid fast staining were  
done to identify parasites. 
 
 Rota virus antigen detection was done for all samples by ELISA. 24 samples 
showed positivity. Reverse Transcriptase Polymerase chain Reaction was done for 
determination of G and P genotype of the rota virus strains. 
The results of these tests are as follows: 
 
 
 
 
 
 
 
 
 
TABLE 1: Age distribution among study and control group 
 
 
 
Most of the children were in the age group of 7-12 months. The study and 
control group were similar in age distribution. 
 
 
 
 
Age (months) Study Control 
No. % No. % 
0 to 6 10 6.7 3.0 6.0 
7 to 12 76 50.7 23 46 
13 to 24 43 28.7 12 24 
25 to 60 21 14 12 24 
Total 150 100 50 100 
Mean age 16.2 ± 11 sd months 18.9±12.2 sd months 
Difference of 
means 
2.7 
‘t’ value 1.456 
Degree of freedom 1.98 
p value 1.47 
TABLE 2: Gender distribution of study (n=150) and control group (n=50)  
 
Age (mths) 
 
Study group Control 
group 
Study group Control group 
 Male % male % female % female % 
0 to 6 4    2.7 2 4 6  4 1 2 
7 to 12 42 28 12 24 34 22.7 11 22 
13 to 24 25 16.7 6 12 18 12 6 12 
25 to 60 15 10 8 16 6 4 4 8 
Total 86 57.3 28 56 64 42.7 22 44 
Significance                          p>0.05                            p>0.05 
 
The study group and control group were similar in gender distribution. In the study 
group and control group, the male to female ratio was 1.3 :1.  
 
TABLE 3:  Duration of diarrhoea 
 
Range Mean duration 
24 hrs to 120 hrs 60.6±30.9 hrs 
 
The mean duration of diarrhoea in study group was 60.6±30.9 hrs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 4: Breast feeding status among study and control group 
 
 
Breast feeding 
status 
Study 
group 
 
Control 
group 
Total Chisquare 
 
 
 
 
 
8.099 
degree 
of 
freedom 
 
 
        
      1 
p value 
 
 
 
 
 
<0.01 
No. % No. % No. % 
Children breast 
fed 
83 55.3 39 78 122 61 
Children not 
breast fed 
67 44.7 11 22 78 39 
 
 The children in the control group had significant breast feeding status  than the study 
group. 
 
         
 
 
 
 
 
 
 
 
 
 
       TABLE 5: Isolates identified  from  stool samples of study  and control group  
  Organism 
Study group Control group  
SignificanceNo.of org 
identified % 
No.of org 
identified 
% 
Bacterial 
isolate 
Escherichia coli 127 84.7 38 76 p>0.05 
EHEC(Enterohaemorrhagic 
E.coli) 
4.0 2.7 0 0 - 
Shigella sp 15 10 0 0 - 
Vibrio choleraeO1Eltor 1 0.7 0 0 - 
Salmonella species 2 1 0 0 - 
Klebsiella species 21 14 15 30 p>0.05 
Pseudomonas species 8 5.3 3 6 p>0.05 
Proteus sp 5 3.3 2 4 p>0.05 
Staphylococcus aureus 4 2.7 1 2 p>0.05 
Enterococci 8 5.3 2 4 p>0.05 
Parasites Giardia lamblia 2 1.3 0 0 - 
Cryptosporidium parvum 2 1.3 0 0 - 
Entamoeba histolytica cyst 5 3.3 1 2 P>0.05 
Ascaris lumbricoides 1 0.7 0 0 - 
Virus Rota virus 24 16 0 0 - 
 
Rota virus  (16% )were identified significantly in the study group followed by 
Shigella  isolates(10%), EHEC isolates(2.7%), Salmonella  isolates (1 %), Vibrio 
cholerae  isolates(0.7% ) .  
  
 
 
 
 
 
 
 
TABLE 6: Antimicrobial susceptibility of isolates of Shigella(n=15), Salmonella 
(n=2) and Vibrio cholerae (n=1) isolates 
 
No. of 
Shigella 
isolates 
sensitive 
% 
No.of 
Salmonella 
isolates 
sensitive 
% 
No.of 
Vibrio 
isolates 
sensiti
ve 
% 
Ampicillin          
10 mcg 
0 0 1 50 1 100 
Cotrimoxazole 
1.25/3.75 mcg 
0 0 2 100 0 0 
Ciprofloxacin       
5 mcg 
15 100 2 100 - - 
  Cefotaxime        
30 mcg 
9 33.3 2 100 - - 
Gentamycin        
10 mcg 
15 100 2 100 - - 
Amoxy clav     
20/10 mcg
9 33.3 2 100 - - 
Chloramphenicol 
30 mcg 
- - - - 1 100 
Tetracycline        
30 mcg 
- - - - 1 100 
 
All  the Shigella  isolates were sensitive to ciprofloxacin, gentamycin and  none 
of them sensitive to ampicillin and cotrimoxazole. All the Salmonella isolates were 
sensitive to ciprofloxacin,  gentamycin,cefotaxime , amoxy clavulanic acid and 
cotrimoxazole. Vibrio cholerae was sensitive to Ampicillin, Chloramphenicol, 
tetracycline and resistant to cotrimoxazole. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
TABLE 7: Breast feeding status among rota virus positive patients and non 
rota virus patients 
 
 
Breast feeding 
status 
Rotavirus 
patients 
Non 
rotavirus 
patients 
p 
value 
deg of 
freedom Chisquare
No. % No. %  
 
>0.05 
 
 
1 
 
 
1.043 
children breast 
fed 
11 45.8 72 57.1
children not  
breast fed 
13 54.2 54 42.9
 
Breast feeding status was found in 45.8% of rota virus patients and 57.1% of non 
rotavirus patients.  
 
 
 
 
 
 
 
 
 
 
 
TABLE 8: Selected clinical data of the most important etiological agents 
 
Rota virus  and Vibrio cholerae  infected patients presented as watery diarrhoea 
associated with  vomiting. Shigella and Salmonella infected patients presented as 
bloody diarrhoea associated with abdominal pain and fever. Cryptosporidium  and 
Giardia infected patients presented as watery diarrhoea and abdominal pain. 
 
 
 
 
 
 
 
 
Organism No. of patients 
No. of patients  with 
watery 
diarrhoea 
bloody 
diarrhoea Fever
abdominal 
pain vomiting 
Rota virus 24 24 0 16 0 20 
Shigella spp 15 10 10 11 09 05 
Salmonella spp 2 2 1 2 2 1 
Vibrio  cholerae 1 1 0 0 0 1 
Giardia lamblia 2 2 0 0 2 0 
Cryptosporidium 
parvum 
2 2 0 0 2 0 
 TABLE 9: 
Correlation of clinical severity in rota virus and non rota virus patients 
 
Clinical 
symptom 
Rotavirus diarrhoea 
patients(n=24) 
Non rota diarrhoea 
patients(n=126) p value 
No.  % No. % 
Fever 16 66.7 77 61.1 p>0.05 
≥6 watery 
stools per day 
17 70.8 50 39.7 p<0.01 
Vomiting 20 83.3 67 53.2 p<0.001 
vomiting ≥4 
times per 24 
hrs 
11 45.8 27 21.4 p<0.05 
bloody stools 0       0 20 15.9 - 
 
A significantly higher proportion of rota virus patients than non rota virus patients 
were associated with more than 6 watery stools per day(70.8% ) and increased bouts 
of vomiting (45.8%). 
 
 
 
 
TABLE 10: Distribution of severe dehydration by age group among rota virus 
and non rota virus diarrhoea patients 
 
Age group 
(mths) 
Rotavirus 
diarrhoea(n=24) % 
Non rotavirus 
diarrhoea(n=126) % p value 
0-6 0 0 1 0.8 - 
7-12 4 16.7 12 9.5 p>0.05 
13-24 3 12.5 3 2.4 p>0.05 
25-60 0 0 2 1.6 - 
Total 7 29.2 18 14.3 p>0.05 
  
29.2% of  rota virus patients were  associated with severe dehydration out of which 
most of them were in 7-12 months age group.  
 
 
 
 
 
 
 
 
 
 
TABLE 11: Age wise analysis of group A rota virus infection among children 0-5 
years with diarrhoea 
Age in mths 
Rotavirus 
patients(n=24) 
Non rotavirus 
patients(n=126) p value 
No. % No. % 
0-6 2 8.3 8 6.3 p>0.05 
7-12 17 70.8 59 46.8 p<0.05 
13-24 4 16.7 37 29.4 p>0.05 
25-60 1 4.2 22 17.5 p<0.05 
 
Overall rota virus infection rate of 16% was found among children with acute 
diarrhoea. Rota virus positive children were significantly higher in the age group 7-12 
months and significantly lesser in the age group 25-60 months.   
 
 
 
 
TABLE 12: Gender wise analysis of rota virus patients  and non rota virus 
patients 
 
 
male(n=86) female(64) 
p value 
No. % No. % 
Rotavirus 
patients(n=24) 
15 17.4 9.0 14.1  
p>0.05 
Non rotavirus 
patients(n=126) 
71 82.6 55 85.9 
 
 The incidence of rota virus was 17.4% in male children and 14.1% in female children.  
 
TABLE 13:  Group A rota virus types detected by RT-PCR(n=12) 
 
No of strains typed by RT-PCR 12 100% 
No of strains  fully typed 8 66.7% 
No of strains  partially typed 1 8.3% 
No of strains  untypeable 3 25% 
 
 Out of 24 rota virus strains ,12 were subjected to typing by RT PCR. Out of 12 strains 
,66.67% were fully typed for G and P genotype,8.33% were partially typed and 25% 
were not typeable.  
 
 
TABLE 14:  Distribution of typed and untyped rota virus strains  
 G type P type Total strains 
Typeable 9(75%) 8(66.7) 12(100%) 
Nontypeable 3(25%) 4(33.3) 12(100%) 
 
Out of 12 rota virus strains, 75% of G genotype and 66.7% of P genotype  could be 
determined.   25% of G genotype and 33.3% of P genotype  could not be determined.  
 
TABLE 15: Distribution of G and P genotype of group A rota virus detected 
among under five children with diarrhoea 
 
 Genotype No of strains % 
G 
type(n=9) 
G1 6 66.7 
G2 2 22.2 
G10 1 11.1 
P 
type(n=8) 
P[8] 6 75 
P[4] 2 25 
 
The G1 genotype was identified in 66.7% of rota virus strains, followed by G2 in 
22.2%  and G10 in 11.1%. P[8] was identified in 75% of the strains and P[4] in 25% 
of the strains. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
TABLE  16: Distribution of G and P type combination of group A rota virus 
strains detected among under five children with diarrhoea 
 
GP type No of strains % 
G1P[8] 6 50 
G2P[4] 2 25 
G10P [untypeable] 1 25 
Total 9 100 
 
G1P[8] was determined in 50% of the strains, followed by G2P[4] in 25% and 
G10P[untypeable] in 25% of the strains. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
DISCUSSION 
Acute infectious diarrhoea is one of the major causes of mortality in children, 
particularly in developing countries like India. Children under 3 years of age may 
experience as many as 10 episodes of diarrhoea per year47. Rotavirus is among the 
most common causes of diarrhoea worldwide18,47 accounting for 134 million 
episodes/year47,92,93.  
 
Effective control of  rota viral disease in any community depends upon an 
accurate understanding of disease burden and knowledge of the relative importance of 
circulating serotypes. This study was conducted to determine bacterial, parasitic 
profile and rotavirus detection and characterization of rota virus in children under 5 
years of age with acute diarrhoea.  
 
In the present study, the study and control group were similar in age 
distribution. Most of the children in the study group(50.7%)  were in the age group of 
7-12 months..(Table 1). This correlates with  John Albert, M. et al39 study in which 
58.5% of diarrhoeal patients were in the age group 0-12 months. 
 
             In the present study, the study group and control group were similar in gender 
distribution. In the study group and control group, the male to female ratio was   1.3:1. 
(Table 2) Thus both the study and control groups were comparable. The present study 
is in accordance with the study conducted by Mohammad Youssef et al60 study in 
which male and female ratio was 1.3:1 and in  John Albert, M. et al39 study ,the ratio 
was 1:0.7.                 
In the study group, the mean duration of diarrhoea was 60.6±30.9 hrs. (Table 
3). This study correlates with study by Nakawesi et al64 in which the mean duration of 
diarrhoea was 90 hrs. 
 
     In this study 55.3% and 78% of children were breast fed in study and control 
group respectively. (Table 4). Since the breast feeding rate was low in study group, 
they were more prone to infection and diarrhoea.  
 
In the present study, Rota virus was detected in 16% of the study group. The 
true incidence of rota virus could be higher than 16% as this data represents only 
children with diarrhoea requiring medical attention.  
 
Distribution of  rota virus in different studies: 
 
Study % 
Present study 16 
P.Saravanan et al72 22.5 
S. S. R. Ajjampur et al91 25.3 
Gagandeep  Kang et al30 study 33 
 
Rota virus was not detected from any one of the control group. This implies 
that rota virus was  significantly associated with diarrhoea.(Table 7). This correlates 
with the study of  M.Aminu et al55 in which rota virus was not detected in controls. 
 
 
Distribution of  bacterial pathogens in different studies 
 
Study Organism % 
Present study Shigella spp 10 
John Albert et al39 Shigella spp 9.2 
Gopinath Balakrish Nair et al32 Shigella spp 7.9 
Present study Vibrio cholerae  0.7 
S. S. R. Ajjampur et al91 Vibrio cholerae 0.6 
Present study Salmonella spp 1 
Iruka N et al36 Salmonella spp 0.9 
Present study EHEC 2.7 
Patrick et al77a EHEC 1.4 
 
  The detection of EHEC  would avoid unnecessary diagnostic imagings and 
surgeries on patients infected with EHEC in search of cause of bloody diarrhoea. Also 
it avoids deleterious antimicrobial and antimotility treatment. Because quinolones 
which are prescribed for majority of patients are potent inducers of shiga toxin 
encoding bacteriophages and toxin production in EHEC, early detection helps in 
identification and monitoring of patients at risk of progression to haemolytic uraemic 
syndrome.   
 
The above mentioned pathogens were obtained only from study group and 
none of these isolates from control group. The bacterial pathogens Shigella  spp and 
Salmonella spp were confined mainly to the study group. This correlates with the 
study by T.I.Ogunsanya et al95in which Shigella spp and Salmonella spp.were 
confined mainly to the diarrhoeal group.  
 
Distribution of parasites in different studies: 
 
Study Organism % 
Present study Giardia lamblia 1.3 
S. S. R. Ajjampur et al91 Giardia lamblia 0.63 
Present study Cryptosporidium parvum 1.3 
S Das et al90 Cryptosporidium parvum 1.4 
Mohammad Youssef et al 60 Cryptosporidium parvum 1.5 
Present study Entamoeba histolytica 3.3 
S. Das et al90 Entamoeba histolytica 4.8 
 
Giardia lamblia and Cryptosporidium were not identified in controls thus 
significantly associated with diarrhoea. This correlates with the study by S. S. R. 
Ajjampur et al91 in which Giardia and Cryptosporidium were not identified in controls. 
 
Antimicrobial sensitivity of significant isolates in different studies: 
 
Study  Isolate                        Sensitivity pattern 
Present study  Shigella 100% sensitive to ciprofloxacin  and 
gentamycin and 0% sensitive to 
ampicillin and cotrimoxazole 
Roger L.Shapiro 
et al85 
Shigella  100% sensitive to ciprofloxacin  and 
gentamycin and 0% sensitive to 
ampicillin and cotrimoxazole 
S.Das et al90 Shigella 100% sensitive to ciprofloxacin  and 
gentamycin and 0% sensitive to 
cotrimoxazole 
Present study Salmonella 100% were sensitive to ciprofloxacin, 
gentamycin,cefotaxime, cotrimoxazole 
,amoxy clavulanic acid 
Moyo et al62  Salmonella all the isolates(100%) were sensitive to 
ciprofloxacin, cefotaxime 
Present study Vibrio 
cholerae 
sensitive to ampicillin, 
chloramphenicol, , tetracycline and 
resistant to cotrimoxazole 
Roger L.Shapiro 
et al85 
Vibrio 
cholerae 
98% sensitive to tetracycline, 93% to 
ampicillin 100% resistant to 
cotrimoxazole. 
 
 In the present study, most of the bacterial pathogens showed high rate of 
resistance to ampicillin and cotrimoxazole which are used for empirical treatment and 
are readily available over the counter. The high rate of resistance to these antibiotics 
may be because of their indiscriminate use. Hence periodic monitoring of drug 
susceptibility and local information of drug resistance is mandatory for providing  
treatment guidelines for  diarrhoea. 
 
 In the present study, breast feeding status was found in 45.8% of rota virus 
patients and did not demonstrate the protective effect of breast feeding against 
rotavirus diarrhoea.(Table 7). This is in accordance with the study by Wobudeya et 
al108 and Nakawesi et al64 and Linhares et al52 in which they have found no evidence 
of protection of breast feeding against rotavirus diarrhoea . 
  
 Since most of the children in the study were above six months of age and on 
complimentary feeding, the contribution of breast feeding could not be determined 
 
 According to Ebina24a et al, the intestinal mucosa needs continuous bathing 
with antibodies and other anti infective components in breast milk for protection 
against rota virus. So breast feeding may be protective only if it is practised with 
intensity and frequency that allows continuous high protection of the mucosa rather 
than the sporadic small volumes. 
 
 In our study, Shigella infected patients presented as bloody 
diarrhoea(66.7%)and fever(73.3%).(Table 8).This  is in accordance with the study by 
Mohammad Youssef et al60 in which 60% of Shigella infected patients  presented as 
bloody diarrhoea and fever. 
 
Rota virus infected patients presented as watery diarrhoea associated with  
vomiting. A significantly higher proportion of  rota virus patients than non rota virus 
patients were associated with more than 6 watery stools per day(70.8% ) and increased 
bouts of vomiting (45.8%). (Table 9). This study  correlates with the study of Khitam 
Muhsen et al46 in which rota virus infected children significantly presented with more 
watery stools (87.1%) and more vomiting(57.6%). This shows that rota virus is 
associated with more severe illness than other enteropathogens. 
 
In the present study, 29.2% of  rota virus patients were  associated with severe 
dehydration out of which most of them were in 7-12 months age group.(Table 10).   
This correlates with the study by A.K. Siddique et al1 in 16% of rotavirus patients 
presented with severe dehydration and most of them were in 6-11 months age group. 
This shows that children in 7-12 months of age group are at higher risk of death due to 
severe dehydration associated with rota virus infection. 
 
In the present study, rota virus positive children were significantly higher in the 
age group 7-12 months and significantly lesser in the age group 25-60 months.(Table 
11). The present study correlates with the study of  P.Saravanan et al72  , M.John 
Albert et al39 study and A.K.Siddique et al1 in which majority of rota virus positive 
patients were in the age group 7-12 months. 
 
This could be because of protective effect of maternal antibodies in infants<6 
months of age and by the development of natural immunity after successive infections 
in children >2 years of age. This also indicates that prophylactic measures such as 
vaccination should be taken in the first few months of life to prevent rota viral 
infection.  
The incidence of rota virus was 17.4% in male children and 14.1% in female 
children and the incidence rate was similar in both male and female children.(Table 
12) This correlates with the study of  P.Saravanan et al72  in India in which no 
association was found between male(23.9%) and female(21.1%). Another study by 
R.N kalaf  and K.S Ghenghesh80 showed similar rates among male and female 
patients,33.6%(40/119) and 32.1%(26/81). Male and female ratio among rota virus 
positive patients was 1.2:1 in the present study. This correlates with Alicia Sa´nchez-
Fauquier et al5 study which  showed male:female ratio of 1.3:1.  
 
In the present study, 66.7% were fully typed for G and P genotype,8.3% were 
partially typed and 25% were not typeable(Table 13).  This was similar to Vivek jain 
et al103 study which has showed 12% of partially or nontypeable strains in India. 
Moyo et al study61b showed 6.1% of nontypeable strains and 6% of partially  typeable 
strains in Tanzania. 
 
In the present study , 75% of G genotype and 66.67% of P genotype  could be 
determined. 25% of G genotype and 33.33% of P genotype  could not be 
determined.(Table 14) . This correlates with the review study of N.A.Cunliffe et al63 
in which 26% of G genotype and 32% of P genotype  could not be typeable. In a 
review study by Ali M.Kheyami et al4 , 11-31.3% of rota virus strains could not be 
typeable for G type. In a study by Zuccotti et al109 ,19.8 % of rota virus strains could 
not be typeable for  P type.  
 
The nontypeability of strains may be due to the emergence of new strains. 
Since rotaviruses genetically mutate, it is to be expected that sometimes RT-PCR 
methodologies are unable to identify all types. Another reason is that the strain 
untypeable  could be unrecognised which needs further investigation as stated by 
M.Aminu et al55.  
 
In the present study, G1 genotype was identified in 66.7% of rota virus strains 
being the most predominant type  followed by G2 in 22.2%  and G10 in 11.1%. (Table 
15). This correlates with the study of Malek MA et al56 in which G1 was the 
predominant type (80%). Ryuichi Uchida et al88 study showed predominance of G1 
type (77%) among children with rotavirus diarrhoea. Also studies done by Alicia 
Sa´nchez-Fauquier et al5, Zuccotti et al109 ,NishioO et al68, Aminu.M et al55 , Ali 
M.Kheyami et al4, N.A.Cunliffe et al63 showed predominance of G1 type in rota virus 
strains. 
 
Other than the globally common genotypes G1 and G2, G10 genotype was also 
seen in the present study. G10 genotype  has been  reported in  the study by  
Gagandeep  Kang et al30 in children with diarrhoea  in south India. But previous 
studies  by Dunn et al23 and Sukumaran M et al94   have reported G10 type  in 
asymptomatic newborn infants. This implies that G10 genotype is increasingly being 
associated with symptomatic diarrhoea.  G10 has also been reported in the study by 
Zuccotti et al109.  
 
In the present study, P[8] was the predominant P type (75% ) followed by P[4] 
25%. (Table 15) .This correlates with the study by Buesa J et al14(77.1% of P[8]) and 
Zuccotti et al109 in which only p[8] and p[4] types were seen with predominance of 
p[8]. The studies by Ryuichi Uchida et al88 ,  Malek MA et al56  and Moyo et al61b  
showed predominance of P[8] type of about 80-100%. 
 
  In the present study, G1P[8] was determined  as the most common combination 
of G and P type( 50% ), followed by G2P[4] and G10P[untypeable].(Table16). G1P[8] 
andG2P[4] have been described as globally common genotypes in a review study done 
by Gentsch et al31. This study correlates with Khitam Muhsen et al46 study which  has 
shown 49.1% of G1P[8] combination and Buesa J et al14 study in which 42.7% of 
G1P[8] combination was found and Foster et al29 study has shown 40.3% of G1P[8] 
combination. Ryuichi Uchida et al88 study have also reported  predominance of 
G1P[8] combination(70%).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary 
SUMMARY 
 
Stool samples were collected from 150 children with diarrhoea and 50 children 
without diarrhoea. The samples were subjected to saline wet mount, iodine 
mount,modified acid fast staining and culture.The isolates were identified by gram 
staining and biochemical reactions. Rota virus antigen was detected in the samples  by 
VP6 specific monoclonal antibodies in  Antigen capture Enzyme Linked immuno 
Sorbent Assay . The samples which were positive for rota virus were subjected to 
Reverse Transcriptase Polymerase Chain Reaction for characterization of the rota 
virus strains.  
 
In the present study , both the study and control groups were comparable. 
Diarrhoea was common in the age group of 7-12 months of age followed by13-24  
months.  
 
The children in the study group had breast feeding status significantly lesser  
than the control group. 
 
Among the bacterial isolates, Shigella sp, Vibrio sp, Salmonella sp and EHEC  
were seen significantly in the study group children with diarrhoea. All of the Shigella  
and Salmonella isolates were sensitive to ciprofloxacin ,gentamycin and none of the 
isolates were sensitive to ampicillin , cotrimoxazole . 
 
Vibrio isolates were sensitive to ampicillin, chloramphenicol, tetracycline and  
resistant to cotrimoxazole. 
Among the parasites,Giardia lamblia and Cryptosporidium oocysts were 
significantly observed only in the study group. 
 
Rota virus incidence was found to be 16% and it was significantly associated 
with diarrhoea. 
 
This study could not demonstrate the protective effect of breast feeding against 
rotavirus diarrhoea as most of the children were above six months of age. 
 
The main clinical presentation of rota virus infected patients  was watery 
diarrhoea  associated with  vomiting and fever. 
 
When compared with non rotavirus patients, rota virus patients presented 
significantly with more than 6 watery stools, with frequent episodes of vomiting . 
 
Rota virus patients were  associated with severe dehydration out of which most 
of them were in 7-12 months age group.  
 
Major proportion of the rota virus positive cases fell significantly in the age 
group between 7-12 months and no significant association was found in gender 
distribution. 
 
66.7% of the rotavirus strains  were fully typed for G and P genotype,8.3% 
were partially typed and 25% were not typeable.  
 
75% of G genotype and 66.7% of P genotype  could be determined.   
 
G1 genotype was identified as the most predominant type  followed by G2. 
 
Along with  the globally common genotypes G1 and G2, G10 genotype was 
also seen. 
P[8] was the predominant P type  identified followed by P[4] . 
 
G1P[8] was determined  as the most common combination of G and P type 
followed by G2P[4] and G10P[untypeable]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
CONCLUSION 
 
In the present study, rota virus, Shigella sp, Vibrio sp, Salmonella sp, EHEC, 
Giardia lamblia and Cryptosporidium were seen significantly in children with 
diarrhoea. All of the Shigella and Salmonella isolates were sensitive to ciprofloxacin 
and gentamycin. Vibrio cholerae was sensitive to tetracycline which is used for  
chemoprophylaxis and thus holds good still now. High rate of resistance of bacterial 
isolates to cotrimoxazole and ampicillin was seen which recommends continuous 
antibiotic surveillance to monitor development of resistance.  
 
Rota virus incidence was found to be 16%  among children under five years of 
age with diarrhoea.  Majority  of them were in the age group of 7 to 12 months 
associated  with severe dehydration and protective effect of breast feeding was not 
found against rota virus infection in this age group. The genotype combination of rota 
virus identified were G1P[8],G2P[4] and G10P[untypeable]. Thus the present study 
shows significant association of  rota virus in children under five years of age  with 
acute diarrhoea and the prevalence of uncommon genotype G10. 
 
The significant association of rota virus in childhood diarrhoea along with 
clinical severity suggests consideration of a rota virus vaccine in the childhood 
immunization program. In developing countries like India, exposure to an 
environment contaminated with human  and animal faeces and close contact with 
animals in the domestic environment are factors enabling viral reassortment and the 
emergence of new strains.  
Most of the rota virus strains in circulation appear to be like those of common 
genotypes G1-4 which are components of current vaccine. But the non typeable 
strains pose an unknown antigenic challenge to the current vaccine Rotateq. Hence 
continuous and prospective monitoring of circulating strains in a large scale study will 
detect any change in the distribution of rotavirus strains which would influence the 
vaccine based preventive strategies in India. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix  
APPENDIX I 
1. Saline(0.9%Nacl): 
Nacl    0.9g 
Distilled water  100ml 
Dissolve the Nacl in distilled water.sterilize by autoclaving. 
2. Iodine solution; 
Lugol’s iodine diluted 5 times with distilled water. 
Lugol’s iodine: 
Iodine crystals  5g 
Potassium iodide  10g 
Distilled water  100ml 
Potassium iodide is dissolved in distilled water and iodine crystals are added 
slowly.The solution is filtered and kept in stoppered bottle of amber colour. 
 
3. Kinyoun’s Modified Acid Fast Staining: 
Reagents: 
1. 50% ethanol 
Add 50 ml  of absolute ethanol to 50 ml distilled water. 
2.  Kinyoun’s carbol fuchsin 
Dissolve 4 g of basic fuchsin in 20 ml of 95% ethanol(solution A) 
Dissolve 8 g of phenol crystals in 100 ml of distilled water.( solutionB) 
Mix solution A and B. 
3.  1% sulphuric acid 
Add 1 ml of conc.sulphuric acid to 99 ml of distilled water. 
4. Loeffler’s alkaline methylene blue 
Dissolve 0.3 g of methylene blue in 30 ml of 95% ethanol. 
Add 100 ml of dilute(0.01%)potassium hydroxide. 
 
APPENDIX II 
1.Mac Conkey agar 
Peptone     20g 
Sodium taurocholate   5g 
Agar      20g 
Neutral red solution,   2% in 50% ethanol 3.5g 
Lactose,     10 % aqueous solution 100ml 
Dissolve the peptone and taurocholate in the water by heating. Add the 
agar and dissolve it in the steamer or autoclave. If necessary, clear by 
filtration. Adjust the pH 7.5. 
 
2.Xylose lysine deoxycholate agar 
Yeast extract     3g 
Xylose     3.75g 
Lactose     7.5g 
Sucrose     7.5g 
L-Lysine     5.0g 
Sodium Chloride    5.0g 
Sodium deoxycholate   2.5g 
Sodium thiosulphate   6.8g 
Ferric ammonium citrate   0.8g 
Phenol red     0.08g 
Agar      15 g 
Water     1 Litre 
 
Except for the deoxycholate, thiosulphate and ferric ammonium citrate, 
dissolve the ingredients in the water by autoclaving. Cool to 50˚c and add 20ml of 
a solution of sodium thiosulphate 34% and ferric ammonium citrate 4%, and 25 
ml of a solution of sodium deoxycholate 10 %. Adjust the pH to 7.4. 
 
3.Thiosulphate citrate bilesalt sucrose Agar: 
Composition     grams/litre 
Proteose peptone    10.0  
Yeast extract     5 
Sodium thiosulphate   10 
Sodium citrate    10 
Oxgall     8 
Sucrose     20 
Sodium chloride    10 
Ferric citrate     1 
Bromothymol blue    0.04 
Thymol blue     0.04 
Agar      15 
Final pH 8.6±0.2 
Dissolve89 gms in 1000 ml distilled water,heat to boiling to dissolve the medium 
completely.after cooling to 50˚c ,pour into petriplates. 
   
 
4.Selenite F broth 
Sodium hydrogen selenite    4 g 
Peptone      5 g 
Lactose      4 g 
Disodium hydrogen phosphate   9.5 g 
Sodium dihydrogen phosphate   0.5 g 
Sterile water      1 litre 
All the ingredients were dissolved in sterile water with sterile precautions. 
The yellow solution in about 10ml amounts distributed into screw capped 
universal bottles. Steamed for 20 minutes at 100˚c. Adjust pH to 7.1. 
 
5.Mueller- Hinton Agar: 
Beef extract     20 gm 
Acidicase peptone    7.5 gm 
Starch     1.5 gm 
Agar      17 gm 
Distilled water    1000 ml 
The ingredients were dissolved in one liter of distilled water, mixed 
thoroughly. Heated with frequent agitation and boiled for 1 minute. pH adjusted to 
7.4. Sterilized by autoclaving and poured in plates. 
 
 
 
 
IDENTIFICATION OF THE ORGANISM :- 
Organism TSI  C
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Escherichia 
coli 
A/A Not 
utilised + - + AG A - A A 
A A - 
+ 
Shigella 
dysenteriae 
K/A Not 
utilised - - + A - - - - 
  - - 
Shigella 
flexneri 
K/A Not 
utilised - - + A - - - A 
  - - 
Shigella 
boydii 
K/A Not 
utilised - - + A - - - A 
  - - 
Shigella 
sonnei 
K/A Not 
utilised - - + A Late - - A 
  - - 
Salmonella 
typhi 
K/A Not 
utilised - - + A - - A A 
A - - + 
Salmonella 
paratyphi A 
K/A Not 
utilised - - + AG - - A A 
- A - + 
Salmonella 
paratyphi B 
K/A utilised - - + AG - - A A A A - + 
Salmonella 
typhimurium 
K/A utilised - - + AG - - A A A A - + 
Vibrio 
cholerae 
A/A utilised + + + A - A A A  - - + 
Klebsiella 
Pneumoniae 
A/A Utilised - - + AG A A A A + + + - 
Klebsiella 
oxytoca 
A/A Utilised + - + AG A A A A + + + - 
Proteus. 
species 
A/Awith 
H2S v V - + AG - V v + 
  + 
+ 
Pseudomonas 
.aeruginosa 
K/No 
change V - + + - - - - - 
  - + 
 
Note:   A/A = Acid slant / Acid butt,    +   = Positive,    - =   Negative                        
A=Acid production,   AG=Acid and gas production 
 
ZONE SIZE INTERPRETATIVE CHART  ACCORDING TO CLSI 
GUIDELINES-Kirby-Bauer Chart 
 
Sl. No. Drug 
Disk 
Content 
mcg 
Resistant
mm or 
less 
Intermediate 
mm 
Sensitive
mm or 
more 
For 
GNB 
1 
Ampicillin 10 13 mm 14-16 mm 17 mm 
2 Co-trimoxazole 1.25/3.75 10 11-15 16 
5 Ciprofloxacin 5 15 16-20 21 
6 Gentamycin 10 12 13-14 15 
7 Cefotaxime 30 14 15-22 23 
8 Tetracycline 30 11 12-14 15 
9 Chloramphenicol 30 12 13-17 18 
11 Amoxycillin – Clavulanic acid 20/10 13 14-17 18 
 
 
 
 
 
 
APPENDIX III: 
Reagents required for ELISA : 
• Microwell plate, coated with monoclonal antibodies (mouse) against 
rotaviruses 
• Sample-dilution buffer,  
• Wash buffer, phosphate-buffered NaCl solution (10-fold concentrate);  
• Positive control Inactivated monkey rotavirus (SA-11);  
• Conjugate : Peroxidase-conjugated monoclonal antibody (mouse) against 
rotaviruses in stabilised protein solution;  
• Substrate :Urea peroxide/TMB; 
•  Stop reagent, 1 N sulphuric acid 
• Distilled or deionised water 
• Test tubes 
• Disposable pipettes  
•  Vortex mixer  
•  Micropipette for 50 -100 µl and 1 ml volume 
•  Measuring cylinder (1000 ml) 
• Stop clock, Washing unit for mictrotitration pipettes or multichannel pipettes 
(300 µl) 
• Photometer for microwell plates (450 nm and reference filter ≥ 600 nm where 
necessary) 
•  Filter paper (laboratory towels) 
•  Waste container containing 0.5 % hypochlorite solution 
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s st 
7 
to 
10 
72hrs 
vom 
4-6 
epi 
ab
d 
pai
n- 
fev
- bf- no 
sem
i b-   E.coli   
rotn
eg   
70 monisha 
8mth
s fc 
24hr
s st 
7 
to 
10 
no 
vom
ab
d 
pa
+
fev
- bf- no
wat
ery b-
cryptospor
idium E.coli
rotn
eg
71 thannarasu 
1 
5mth
s 
m
c 
24hr
s st 
7 
to 
10 
24hrs 
vom
1-3 
epi
ab
d 
pa
+
fev
+ bf- no
wat
ery b-   S.flexneri
sens to 
cip,gen,cefo,am
clav,res to 
amp,cot
rotn
eg
72 suriya 
12mt
hs 
m
c 
24hr
s st 
>1
0 
24hrs 
vom 
4-6 
epi 
ab
dp 
ne
g 
 
fev
+ bf- 
som
e 
wat
ery b-   K.oxy,   
rot 
pos not typed 
73 
aayisha 
siddika 42m fc 
>72 
hrss
t 
7 
to 
10 
no 
vom   
ab
d 
pa
+ 
fev
+ bf+ 
som
e 
sem
i b+   
E.coli,S.flex
neri 
sens to 
cip,gen,cefo,am
clav,res to 
amp,cot 
rotn
eg   
74 yuvaraj 
21mt
hs 
m
c 
24hr
s st 
4 
to 
6 
24hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b-   E.coli   
rotn
eg   
75 gunal 
10mt
hs 
m
c 
24hr
s st 
4 
to 
24hrs 
vom 
4-6 
epi 
ab
d 
fev
- bf+ no 
wat
ery b-   k.oxy,E.coli   
rotn
eg   
6 pai
n-
76 lathika 
8mth
s fc 
72hr
s st 
4 
to 
6 
24hrs 
vom
4-6 
epi
ab
d 
pai
n-
fev
- bf+
sev
ere
sem
i b +   EH E.coli
rotn
eg
77 
Dhanalaks
hmi 
36mt
hs fc 
>72 
hrss
t 
4 
to 
6 
48hrs 
vom 
4-6 
epi 
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b-   E.coli   
rotn
eg   
78 jothi 
36mt
hs fc 
48 
hrs 
st 
4 
to 
6 
no 
vom 
4-6 
epi 
ab
d 
pa
+ 
fev
+ bf- no 
wat
ery b + EH cyst 
S.paratyphi
A 
sen to 
cip,cefo,amclav
,gen, cot,ampi 
rotn
eg   
79 
Monish 
babu 
36mt
hs 
m
c 
72hr
s st 
>1
0 
48hrs 
vom 
4-6 
epi 
ab
d 
pa
+ 
fev
+ bf- 
som
e 
wat
ery b-   k.oxy,E.coli   
rotn
eg   
80 
Srikrishna
n 
9mth
s 
m
c 
72hr
s st 
4 
to 
6 
72hrs 
vom 
7-10 
epi 
ab
d 
pai
n- 
fev
+ bf+ no 
wat
ery b-   K.oxy   
rotn
eg   
81 Ashika 
10mt
hs fc 
24hr
s st 
4 
to 
6 
no 
vom   
ab
dp 
ne
g 
fev
- bf- 
som
e 
wat
ery b-   E.coli   
rot 
pos not typed 
82 Tamilarasu 
11mt
hs 
m
c 
24hr
s st 
4 
to 
6 
24hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf+ no 
wat
ery b-   E.coli,k.oxy   
rotn
eg   
83 
Maheswar
an 
12mt
hs 
m
c 
>72
hrs 
st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b+   
S.flexneri,E
.coli 
sens to 
cip,gen,cefo,am
clav,res to 
amp,cot 
rotn
eg   
84 Iniya 
15mt
hs fc 
72hr
s st 
4 
to 
6 
72hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
- bf- no 
wat
ery b-   E.coli   
rotn
eg   
85 Akshara 
15mt
hs fc 
>72
hrs 
st 
4 
to 
6 
no 
vom   
ab
d 
pa 
+ 
fev
+ bf- 
som
e 
wat
ery b+   E.coli   
rotn
eg   
86 Sanjana 
7mth
s fc 
72hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
- bf+ no 
wat
ery b-   K.oxy   
rotn
eg   
87 
Thiyagaraj
an 
9mth
s 
m
c 
>72
hrs 
st 
4 
to 
6 
24hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf+ 
som
e 
wat
ery b-   E.coli   
rotn
eg   
88 Joefelix 
8mth
s 
m
c 
24hr
s st 
7 
to 
10 
24hrs 
vom 
1-3 
epi 
ab
dp 
ne
g 
fev
+ bf- no 
wat
ery b-   E.coli   
rot 
pos untypeable 
89 Gokulesh 
36mt
hs 
m
c 
>72
hrs 
st 
4 
to 
6 
no 
vom
ab
d 
pa 
+
fev
- bf+
som
e
wat
ery b- Giardia E.coli
rotn
eg
90 Shalini 
6mth
s fc 
48hr
s st 
4 
to 
6 
24hrs 
vom
1-3 
epi
ab
d 
pai
n-
fev
- bf- no
wat
ery b-   
E.coli,K.ox
y
rotn
eg
91 Kaavya 
10mt
hs fc 
>72
hrs 
st 
7 
to 
10 
no 
vom   
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b-   
pseudo,E.co
li   
rotn
eg   
92 
Mohanakri
shnan 
9mth
s 
m
c 
72hr
s st 
7 
to 
10 
48hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf- 
som
e 
wat
ery b-   E.coli   
rotn
eg   
93 Dharshan 
6mth
s 
m
c 
72hr
s st 
4 
to 
6 
>72hr
s vom 
1-3 
epi 
ab
dp 
ne
g 
fev
- bf+ no 
wat
ery b-   E.coli   
rot 
pos 
G10P[untyp
eable] 
94 Divya 
36mt
hs fc 
>72
hrs 
7 
to 
no 
vom   
ab
d 
fev
- bf- no 
wat
ery b- 
cryptospor
idium K.oxy   
rotn
eg   
st 10 pa
+
95 Nithilan 
18mt
hs 
m
c 
>72
hrs 
st 
>1
0 
no 
vom
ab
d 
pa 
+
fev
+ bf-
som
e
wat
ery b+   
E.coli,S.flex
neri
sens to 
cip,gen,cefo,am
clav,res to 
amp,cot
rotn
eg
96 
Mohan 
kumar 
7.5m
ths 
m
c 
48hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pa
+ 
fev
+ bf+ 
sev
ere 
wat
ery b-   
E.coli,K.ox
y   
rotn
eg   
97 Mani 
8mth
s 
m
c 
72hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b-   E.coli   
rotn
eg   
98 Agilesh 
8mth
s 
m
c 
72hr
s st 
4 
to 
6 
48hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
- bf- 
som
e 
wat
ery b-   Proteus   
rotn
eg   
99 Jeeva 
36mt
hs 
m
c 
48hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pa
+ 
fev
+ bf+ no 
wat
ery b-   
entero,E.col
i   
rotn
eg   
100 Sriram 
18mt
hs 
m
c 
48hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
+ bf+ no 
wat
ery b-   E.coli   
rotn
eg   
101 
Tamil 
sekuvara 
14mt
hs 
m
c 
48hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
- bf+ no 
wat
ery b-   E.coli   
rotn
eg   
102 Lokesh 
18mt
hs 
m
c 
>72
hrs 
st 
4 
to 
6 
72hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
- bf+ no 
wat
ery b-   
pseudo,E.co
li   
rotn
eg   
103 Prabakaran 
24mt
hs 
m
c 
48hr
s st 
7 
to 
10 
48hrs 
vom 
4-6 
epi 
ab
dp 
ne
g 
 
fev
+ bf- 
som
e 
wat
ery b-   E.coli   
rot 
pos G1P[8] 
104 Vignesh 
18mt
hs 
m
c 
>72
hrs 
st 
>1
0 
>72hr
s vom 
4-6 
epi 
ab
d 
pai
n- 
fev
+ bf- 
som
e 
wat
ery b-   E.coli   
rotn
eg   
105 Naren bose 
18mt
hs 
m
c 
24hr
s st 
4 
to 
6 
24hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf+ no 
wat
ery b-   E.coli   
rotn
eg   
106 Kamalesh 
11mt
hs 
m
c 
72hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
- bf- no 
sem
i b+   
S.flexneri,E
.coli 
sens to 
cip,gen,cefo,am
clav,res to 
amp,cot 
rotn
eg   
107 Sanjay 
36mt
hs 
m
c 
>72
hrs 
st 
4 
to 
6 
no 
vom   
ab
d 
pa
+ 
fev
+ bf- no 
wat
ery b-   
E.coli,enter
o   
rotn
eg   
108 
afra 
fathima  
12mt
hs fc 
>72
hrs 
st 
7 
to 
10 
no 
vom
ab
d 
pai
n-
fev
- bf-
sev
ere
wat
ery b-   E.coli
rotn
eg
109 yuvaraj 
21mt
hs 
m
c 
24hr
s st 
4 
to 
6 
24hrs 
vom
1-3 
epi
ab
d 
pai
n-
fev
+ bf- no
wat
ery b-   proteus
rotn
eg
110 gunal 
10mt
hs 
m
c 
24hr
s st 
7 
to 
10 
24hrs 
vom 
4-6 
epi 
ab
dp 
ne
g 
fev
+ bf+ no 
wat
ery b-   k.oxy   
rot 
pos not typed 
111 rahul 
12mt
hs 
m
c 
72hr
s st 
7 
to 
10 
no 
vom   
ab
d 
pa
+ 
fev
+ bf- 
sev
ere 
sem
i b+   
S.flexneri,E
.coli 
sens to 
cip,gen,cefo,am
clav,res to 
amp,cot 
rotn
eg   
112 Abudali 
51mt
hs 
m
c 
24hr
s st 
7 
to 
10 
24hrs 
vom 
4-6 
epi 
ab
d 
pai
n- 
fev
+ bf+ 
som
e 
wat
ery b- EH cyst E.coli   
rotn
eg   
113 
Katheeja 
suhaina 
24mt
hs fc 
48hr
s st 
4 
to 
no 
vom   
ab
d 
fev
+ bf- no 
wat
ery b-   E.coli   
rotn
eg   
6 pai
n-
114 Dhanush 
24mt
hs 
m
c 
48hr
s st 
4 
to 
6 
no 
vom
ab
d 
pai
n-
fev
+ bf- no
wat
ery b-   E.coli
rotn
eg
115 Santhosh 
18mt
hs 
m
c 
>72
hrs 
st 
4 
to 
6 
>72hr
s vom 
4-6 
epi 
ab
d 
pai
n- 
fev
+ bf+ 
som
e 
wat
ery b-   E.coli   
rotn
eg   
116 Bavani 
24mt
hs fc 
48hr
s st 
>1
0 
24hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b-   k.oxy,E.coli   
rotn
eg   
117 Jaidev 
9mth
s 
m
c 
24hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
+ bf+ no 
wat
ery b-   E.coli   
rotn
eg   
118 Manoj 
7mth
s 
m
c 
>72
hrs 
st 
7 
to 
10 
no 
vom   
ab
dp 
ne
g 
fev
- bf+ 
som
e 
wat
ery b-   E.coli   
rot 
pos not typed 
119 
Jayananthi
ni 
18mt
hs fc 
72hr
s st 
7 
to 
10 
72hrs 
vom 
4-6 
epi 
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b-   E.coli   
rotn
eg   
120 Valanshika 
12mt
hs fc 
72hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b-   E.coli   
rotn
eg   
121 Balaji 
18mt
hs 
m
c 
24hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
- bf+ no 
sem
i b-   E.coli   
rotn
eg   
122 
Angel 
christina 
12mt
hs fc 
>72
hrs 
st 
7 
to 
10 
72hrs 
vom 
4-6 
epi 
ab
d 
pa
+ 
fev
+ bf- no 
wat
ery b+   
S.typhimuri
um 
sen to 
cip,cefo,amclav
,gen, cot res to 
ampi 
rotn
eg   
123 Tarun 
18mt
hs 
m
c 
72hr
s st 
>1
0 
24hrs 
vom 
4-6 
epi 
ab
dp 
ne
g 
 
fev
+ bf+ 
sev
ere 
wat
ery b-   E.coli   
rot 
pos not typed 
124 Mani 
8mth
s 
m
c 
72hr
s st 
4 
to 
6 
24hrs 
vom 
4-6 
epi 
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b-   
proteus,E.c
oli   
rotn
eg   
125 Jacob 
7mth
s 
m
c 
24hr
s st 
4 
to 
6 
24hrs 
vom 
4-6 
epi 
ab
d 
pai
n- 
fev
- bf+ no 
wat
ery b-   E.coli   
rotn
eg   
126 
Praveen 
kumar 
18mt
hs 
m
c 
48hr
s st 
7 
to 
10 
no 
vom   
ab
d 
pai
n- 
fev
- bf- no 
wat
ery b-   E.coli   
rotn
eg   
127 vijoovan 
6mth
s 
m
c 
>72
hrs 
st 
4 
to 
6 
no 
vom
ab
d 
pai
n-
fev
+ bf+
som
e
sem
i b-   k.oxy.E.coli
rotn
eg
128 Sasikumar 
54mt
hs 
m
c 
72hr
s st 
4 
to 
6 
24hrs 
vom
4-6 
epi
ab
d 
pai
n-
fev
+ bf+ no
wat
ery b-
Ascaris 
egg k.oxy
rotn
eg
129 Vishwa 
18mt
hs 
m
c 
24hr
s st 
4 
to 
6 
24hrs 
vom 
4-6 
epi 
ab
d 
pai
n- 
fev
- bf+ 
sev
ere 
wat
ery b-   E.coli   
rotn
eg   
130 Srinivas 
48mt
hs 
m
c 
24hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
- bf- 
som
e 
sem
i b-   
E.coli,prote
us   
rotn
eg   
131 Akash 
18mt
hs 
m
c 
24hr
s st 
4 
to 
6 
24hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
- bf- no 
sem
i b-   E.coli   
rotn
eg   
132 Ayyanaar 
32mt
hs 
m
c 
24hr
s st 
4 
to 
no 
vom   
ab
d 
fev
- bf+ no 
wat
ery b-   
pseudo,E.co
li   
rotn
eg   
6 pai
n-
133 
Mohamme
d Farook 
11mt
hs 
m
c 
72hr
s st 
7 
to 
10 
72hrs 
vom
4-6 
epi
ab
dp 
ne
g
fev
+ bf+
sev
ere
wat
ery b-   E.coli
rot 
pos G1P[8]
134 Sri sanjeev 
8mth
s 
m
c 
>72
hrs 
st 
7 
to 
10 
>72hr
s vom 
4-6 
epi 
ab
d 
pai
n- 
fev
- bf+ no 
wat
ery b-   
k.oxy,enter
o   
rotn
eg   
135 sree 
15mt
hs 
m
c 
48hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pa 
+ 
fev
+ bf- no 
sem
i b-   E.coli   
rotn
eg   
136 
Shek 
rehman 
10mt
hs 
m
c 
72hr
s st 
7 
to 
10 
72hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
- bf+ 
sev
ere 
sem
i b-   
entero,E.col
i   
rotn
eg   
137 Nivedha 
24mt
hs fc 
>72
hrs 
st 
7 
to 
10 
no 
vom   
ab
d 
pai
n- 
fev
+ bf- 
som
e 
wat
ery b-   E.coli   
rotn
eg   
138 
Naresh 
kumar 
21mt
hs 
m
c 
>72
hrs 
st 
4 
to 
6 
72hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf- no 
wat
ery b-   E.coli   
rotn
eg   
139 Rithika 
18mt
hs fc 
24hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
+ bf+ no 
wat
ery b-   k.oxy   
rotn
eg   
140 Sylvia 
9mth
s fc 
48hr
s st 
4 
to 
6 
48hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf+ 
sev
ere 
wat
ery b-   EH E.coli   
rotn
eg   
141 
Muvin 
kumar 
7mth
s 
m
c 
48hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
- bf+ no 
wat
ery b-   E.coli   
rotn
eg   
142 Sahistha 
10mt
hs fc 
48hr
s st 
4 
to 
6 
no 
vom   
ab
d 
pai
n- 
fev
- bf+ 
sev
ere 
wat
ery b-   
S.aureus,E.c
oli   
rotn
eg   
143 Vandhana 
24mt
hs fc 
24hr
s st 
4 
to 
6 
24hrs 
vom 
1-3 
epi 
ab
d 
pa
+ 
fev
- bf- no 
wat
ery b+   S.flexneri 
sens to 
cip,gen,cefo,am
clav,res to 
amp,cot 
rotn
eg   
144 Doyal 
12mt
hs 
m
c 
24hr
s st 
7 
to 
10 
24hrs 
vom 
4-6 
epi 
ab
dp 
ne
g 
 
fev
+ bf- no 
wat
ery b-   E.coli   
rot 
pos G1P[8] 
145 
David 
jebaselvan 
12mt
hs 
m
c 
48hr
s st 
4 
to 
6 
48hrs 
vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf+ no 
sem
i b-   
pseudo,E.co
li   
rotn
eg   
146 Uday 
9mth
s 
m
c 
72hr
s st 
4 
to 
6 
no 
vom
ab
d 
pai
n-
fev
- bf+
sev
ere
wat
ery b-   E.coli
rotn
eg
147 
vijayakum
ari 
12mt
hs fc 
24hr
s st 
4 
to 
6 
no 
vom
ab
d 
pa
+
fev
+ bf- no
sem
i b-   k.oxy,E.coli
rotn
eg
148 pooja sree 
18mt
hs fc 
48hr
s st 
7 
to 
10 
no 
vom   
ab
d 
pa
+ 
fev
+ bf+ no 
wat
ery b-   E.coli   
rotn
eg   
149 swathi 
9mth
s fc 
>72
hrs 
st 
4 
to 
6 
>72hr
s vom 
1-3 
epi 
ab
d 
pai
n- 
fev
+ bf+ no 
wat
ery b-   E.coli   
rotn
eg   
150 jothi 
24mt
hs fc 
48hr
s st 
4 
to 
6 
48hrs 
vom 
4-6 
epi 
ab
d 
pai
n- 
fev
+ bf+ no 
wat
ery b-   E.coli   
rotn
eg   
 
CONTROLS 
SL. NO AGE SEX BREAST FEED BACTERIA PARASITE ROTA VIRUS 
1 6mths mc bf+ E.coli   rot neg 
2 12mths mc bf+ E.coli,k.oxy   rot neg 
3 18mths fc bf+ E.coli   rot neg 
4 15mths fc bf- E.coli,pseudo   rot neg 
5 30mths mc bf+ k.oxy EH cyst rot neg 
6 7mths mc bf+ E.coli   rot neg 
7 8mths fc bf+ E.coli,k.oxy   rot neg 
8 36mths fc bf+ k.oxy   rot neg 
9 18mths fc bf+ E.coli   rot neg 
10 9mths mc bf+ E.coli   rot neg 
11 6mths fc bf+ E.coli.k.oxy   rot neg 
12 32mths mc bf+ k.oxy   rot neg 
13 24mths mc bf+ E.coli   rot neg 
14 12mths fc bf+ E.coli rot neg 
15 24mths fc bf+ pseudo   rot neg 
16 50mths mc bf- E.coli EH cyst rot neg 
17 8mths mc bf+ E.coli   rot neg 
18 21mths mc bf+ E.coli   rot neg 
19 36mths mc bf- k.oxy   rot neg 
20 6mths mc bf+ E.coli   rot neg 
21 12mths mc bf+ E.coli,entero   rot neg 
22 30mths mc bf- k.oxy   rot neg 
23 24mths fc bf+ E.coli,k.oxy rot neg 
24 9mths fc bf+ E.coli   rot neg 
25 36mths fc bf- k.oxy   rot neg 
26 12mths mc bf+ E.coli   rot neg 
27 12mths fc bf+ E.coli,k.oxy   rot neg 
28 40mths mc bf- E.coli EH cyst rot neg 
29 9mths fc bf+ E.coli rot neg 
30 18mths mc bf+ E.coli,proteus   rot neg 
31 7mths mc bf+ E.coli   rot neg 
32 7.5mths fc bf+ E.coli   rot neg 
33 32mths mc bf+ pseudo   rot neg 
34 24mths mc bf- E.coli,k.oxy   rot neg 
35 12mths mc bf+ E.coli   rot neg 
36 9mths fc bf+ E.coli   rot neg 
37 18mths fc bf- S.aureus rot neg 
38 8mths mc bf+ E.coli   rot neg 
39 24mths mc bf+ E.coli   rot neg 
40 8.5mths mc bf+ E.coli   rot neg 
41 42mths fc bf- proteus   rot neg 
42 12mths fc bf+ E.coli,k.oxy   rot neg 
43 9mths mc bf+ E.coli rot neg 
44 8mths fc bf+ E.coli   rot neg 
45 54mths mc bf- entero EH cyst rot neg 
46 32mths fc bf+ E.coli   rot neg 
47 18mths mc bf+ E.coli   rot neg 
48 12mths fc bf+ E.coli,k.oxy   rot neg 
49 24mths fc bf+ E.coli   rot neg 
50 9mths mc bf- k.oxy   rot neg 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key to Master chart 
Key to Master chart 
 
mc   - male child 
fc   - female child 
bf   - breast feeding status 
fev   - fever 
abd pain  - abdominal pain 
vom   - vomiting 
b   - blood stained 
E.coli   - Escherichia coli 
K.oxy   - Klebsiella oxytoca 
K.pneum  - Klebsiella pneumoniae 
Pseudo  - Pseudomonas sp 
Entero   - Enterococci 
S.aureus  - Staphylococcus aureus 
V.cholerae  - Vibrio cholerae 
EH cyst  - Entamoeba histolytica 
Giardia  - Giardia lamblia 
Cryptosporidium - Cryptosporidium parvum 
Rot   - Rota virus antigen 
cip   - ciprofloxacin 
gen   - gentamycin 
cefo   - cefotaxime 
amclav  - amoxy clavulanic acid 
amp   - ampicillin 
cot   - cotrimoxazole 
tet   - tetracycline 
chlor   - chloramphenicol 
sen   - sensitive, 
res   - resistant  
  
 
 
 
 
 
 
 
Proforma 
PROFORMA 
Name   : 
  Age   :   
  Sex   : male/female 
  Address  : 
  OP/IP No  : 
  Micro ID No  : 
  Complaints  : 
  Loose stools  : 
  Nature of stool  :  watery/bloody/mucus 
 Frequency  : 4-6/7-10/>10  episodes/day 
  Duration   : 24 hrs/48 hrs/72 hrs/>72 hrs 
  Vomiting  : 
  Duration  : 
  Abdominal pain : 
  Duration  :  
Fever   : 
   Duration  : 
Cough/running nose: 
Duration  : 
Difficulty in feeding: 
Duration  : 
 
 
 
 
  Coinfections  : 
   Liver disease/Malignancy 
Haematological abnormalities 
Immunodeficiency/Steroids 
Renal disease /Meningitis/Septicaemia  
 
Mode of transmission: 
Food borne(milk,meat,vegetables) 
Fruits & beverages, icecream , sandwich 
Water borne: 
Person to person(contact) 
Animal to human:(milk,undercooked meat) 
Community acquired: 
Past history   : 
Treatment history   : Antibiotics/laxatives     
General examination : 
Dehydration: mild/moderate/severe 
Systemic examination: 
CVS: 
RS: 
Abdomen: 
CNS: 
 
 
 
